290 INSULIN RESISTANCE PREDICTS RISK FOR THE DEVELOPMENT OF VARICEAL BLEEDING (English)
- New search for: Jover, M.
- New search for: Grande, L.
- New search for: Camacho, I.
- New search for: Pardo, B.
- New search for: Figueruela, B.
- New search for: Madrazo, A.
- New search for: Ortiz, C.
- New search for: Sanchez, D.
- New search for: Guerrero, P.
- New search for: Suarez, E.
- New search for: Jover, M.
- New search for: Grande, L.
- New search for: Camacho, I.
- New search for: Pardo, B.
- New search for: Figueruela, B.
- New search for: Madrazo, A.
- New search for: Ortiz, C.
- New search for: Sanchez, D.
- New search for: Guerrero, P.
- New search for: Suarez, E.
In:
JOURNAL OF HEPATOLOGY
;
48
;
S116
;
2008
-
ISSN:
- Article (Journal) / Print
-
Title:290 INSULIN RESISTANCE PREDICTS RISK FOR THE DEVELOPMENT OF VARICEAL BLEEDING
-
Contributors:Jover, M. ( author ) / Grande, L. ( author ) / Camacho, I. ( author ) / Pardo, B. ( author ) / Figueruela, B. ( author ) / Madrazo, A. ( author ) / Ortiz, C. ( author ) / Sanchez, D. ( author ) / Guerrero, P. ( author ) / Suarez, E. ( author )
-
Published in:JOURNAL OF HEPATOLOGY ; 48 ; S116
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2008-01-01
-
Size:S116
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 48
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Letter from the Editor| 2008
- 2
-
Healthcare should not be a vehicle for transmission of hepatitis C virusAlter, M. J. et al. | 2008
- 5
-
Treatment of hepatitis C in HIV-infected persons: A work in progressSulkowski, M. et al. | 2008
- 8
-
Hepatitis C core protein - The "core" of immune deception?Szabo, G. / Dolganiuc, A. et al. | 2008
- 12
-
Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liverYang, F. / Yan, S. / He, Y. / Wang, F. / Song, S. / Guo, Y. / Zhou, Q. / Wang, Y. / Lin, Z. / Yang, Y. et al. | 2008
- 20
-
Hospital admission is a relevant source of hepatitis C virus acquisition in SpainMartnez-Bauer, E. / Forns, X. / Armelles, M. / Planas, R. / Sola, R. / Vergara, M. / Fabregas, S. / Vega, R. / Salmeron, J. / Diago, M. et al. | 2008
- 28
-
Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3Poustchi, H. / Negro, F. / Hui, J. / Cua, I. H. / Brandt, L. R. / Kench, J. G. / George, J. et al. | 2008
- 35
-
Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": Modifications in two large surveys between 2004 and 2006Cacoub, P. / Halfon, P. / Rosenthal, E. / Pialoux, G. / Benhamou, Y. / Perronne, C. / Pol, S. et al. | 2008
- 43
-
Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patientsToyoda, H. / Kumada, T. / Kaneoka, Y. / Murakami, Y. et al. | 2008
- 51
-
Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytesZimmermann, M. / Flechsig, C. / Monica, N. L. / Tripodi, M. / Adler, G. / Dikopoulos, N. et al. | 2008
- 61
-
Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxinGonzalez-Navajas, J. M. / Bellot, P. / Frances, R. / Zapater, P. / Munoz, C. / Garca-Pagan, J. C. / Pascual, S. / Perez-Mateo, M. / Bosch, J. / Such, J. et al. | 2008
- 68
-
Evolution in the management of acute liver failure-associated aplastic anaemia in children: A single centre experienceHadzic, N. / Height, S. / Ball, S. / Rela, M. / Heaton, N. D. / Veys, P. / Mieli-Vergani, G. et al. | 2008
- 74
-
Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalitiesMalamut, G. / Ziol, M. / Suarez, F. / Beaugrand, M. / Viallard, J. F. / Lascaux, A. S. / Verkarre, V. / Bechade, D. / Poynard, T. / Hermine, O. et al. | 2008
- 83
-
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infectionSchmitz, K. J. / Wohlschlaeger, J. / Lang, H. / Sotiropoulos, G. C. / Malago, M. / Steveling, K. / Reis, H. / Cicinnati, V. R. / Schmid, K. W. / Baba, H. A. et al. | 2008
- 91
-
In vivo confocal laser laparoscopy allows real time subsurface microscopy in animal models of liver diseaseGoetz, M. / Vieth, M. / Kanzler, S. / Galle, P. R. / Delaney, P. / Neurath, M. F. / Kiesslich, R. et al. | 2008
- 98
-
Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cellsYang, L. / Wang, Y. / Mao, H. / Fleig, S. / Omenetti, A. / Brown, K. D. / Sicklick, J. K. / Li, Y. X. / Diehl, A. M. et al. | 2008
- 107
-
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cellsRovida, E. / Navari, N. / Caligiuri, A. / Dello Sbarba, P. / Marra, F. et al. | 2008
- 116
-
Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humansKovacs, P. / Kress, R. / Rocha, J. / Kurtz, U. / Miquel, J. F. / Nervi, F. / Mendez-Sanchez, N. / Uribe, M. / Bock, H. H. / Schirin-Sokhan, R. et al. | 2008
- 125
-
Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancySookoian, S. / Castano, G. / Burgueno, A. / Gianotti, T. F. / Pirola, C. J. et al. | 2008
- 133
-
Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 moleculeLim, Y. S. / Oh, H. B. / Choi, S. E. / Kwon, O. J. / Heo, Y. S. / Lee, H. C. / Suh, D. J. et al. | 2008
- 140
-
Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitisAl-Chalabi, T. / Underhill, J. A. / Portmann, B. C. / McFarlane, I. G. / Heneghan, M. A. et al. | 2008
- 148
-
The changing epidemiology of hepatitis C virus infection in EuropeEsteban, J. I. / Sauleda, S. / Quer, J. et al. | 2008
- 163
-
Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenomaRebouissou, S. / Bioulac-Sage, P. / Zucman-Rossi, J. et al. | 2008
- 171
-
Transjugular liver biopsy: A relatively simple procedure with an indefinite past and an expected brilliant futureAlessandria, C. / Debernardi-Venon, W. / Rizzetto, M. / Marzano, A. et al. | 2008
- 172
-
Transjugular liver biopsy: Not a second rate biopsyKalambokis, G. / Manousou, P. / Vibhakorn, S. / Marelli, L. / Cholongitas, E. / Senzolo, M. / Patch, D. / Burroughs, A. K. et al. | 2008
- 174
-
Rosiglitazone: Possible complications and treatment of non-alcoholic steatohepatitis (NASH)Henriksen, J. H. / Ring-Larsen, H. et al. | 2008
- 177
-
Announcements| 2008
- 178
-
List of Referees| 2008
- 183
-
Hepatitis C infection: Dying with or from the infection?El-Serag, H. / Kramer, J. R. et al. | 2008
- 185
-
Predicting failure to control bleeding and mortality in acute variceal bleedingBurroughs, A. K. / Triantos, C. K. et al. | 2008
- 189
-
Bio-artificial liver devices - Tentative, but promising progressStreetz, K. L. et al. | 2008
- 192
-
Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXRScholtes, C. / Diaz, O. / Icard, V. / Kaul, A. / Bartenschlager, R. / Lotteau, V. / Andre, P. et al. | 2008
- 200
-
Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumptionMarcellin, P. / Pequignot, F. / Delarocque-Astagneau, E. / Zarski, J. P. / Ganne, N. / Hillon, P. / Antona, D. / Bovet, M. / Mechain, M. / Asselah, T. et al. | 2008
- 208
-
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infectionWasmuth, H. E. / Zaldivar, M. M. / Berres, M. L. / Werth, A. / Scholten, D. / Hillebrandt, S. / Tacke, F. / Schmitz, P. / Dahl, E. / Wiederholt, T. et al. | 2008
- 216
-
Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infectionScotta, C. / Garbuglia, A. R. / Ruggeri, L. / Spada, E. / Laurenti, L. / Perrone, M. P. / Girelli, G. / Mele, A. / Capobianchi, M. R. / Folgori, A. et al. | 2008
- 229
-
Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapyAbraldes, J. G. / Villanueva, C. / Banares, R. / Aracil, C. / Catalina, M. V. / Garca-Pagan, J. C. / Bosch, J. et al. | 2008
- 237
-
Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalingsSeki, E. / Kondo, Y. / Iimuro, Y. / Naka, T. / Son, G. / Kishimoto, T. / Fujimoto, J. / Tsutsui, H. / Nakanishi, K. et al. | 2008
- 246
-
Effect of aging on EGF-induced proliferative response in primary cultured periportal and perivenous hepatocytesOhtake, Y. / Maruko, A. / Ohishi, N. / Fukumoto, M. / Ohkubo, Y. et al. | 2008
- 255
-
Temporal treatment with interferon-b prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic miceYamazaki, K. / Suzuki, K. / Ohkoshi, S. / Yano, M. / Kurita, S. / Aoki, Y. h. / Toba, K. / Takamura, M. a. / Yamagiwa, S. / Matsuda, Y. et al. | 2008
- 266
-
Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liverPoyck, P. P. / van Wijk, A. C. / van der Hoeven, T. V. / de Waart, D. R. / Chamuleau, R. A. / van Gulik, T. M. / Oude Elferink, R. P. / Hoekstra, R. et al. | 2008
- 276
-
Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytesDemetris, A. J. / Specht, S. / Nozaki, I. / Lunz, J. G. / Stolz, D. B. / Murase, N. / Wu, T. et al. | 2008
- 289
-
Na+/H+ exchanger inhibitor, FR183998, has protective effect in lethal acute liver failure and prevents iNOS induction in ratsTanaka, H. / Uchida, Y. / Kaibori, M. / Hijikawa, T. / Ishizaki, M. / Yamada, M. / Matsui, K. / Ozaki, T. / Tokuhara, K. / Kamiyama, Y. et al. | 2008
- 300
-
Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional studyAllard, J. P. / Aghdassi, E. / Mohammed, S. / Raman, M. / Avand, G. / Arendt, B. M. / Jalali, P. / Kandasamy, T. / Prayitno, N. / Sherman, M. et al. | 2008
- 308
-
Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice modelOrejuela, D. / Jorquera, R. / Bergeron, A. / Finegold, M. J. / Tanguay, R. M. et al. | 2008
- 318
-
Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASHLieber, C. S. / DeCarli, L. M. / Leo, M. A. / Mak, K. M. / Ponomarenko, A. / Ren, C. / Wang, X. et al. | 2008
- 327
-
Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound ironGraham, R. M. / Reutens, G. M. / Herbison, C. E. / Delima, R. D. / Chua, A. C. / Olynyk, J. K. / Trinder, D. et al. | 2008
- 335
-
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factorsGiovanna, F. / Bortolotti, F. / Francesco, D. et al. | 2008
- 353
-
Viral hepatitis and HIV coinfectionSulkowski, M. S. et al. | 2008
- 368
-
Origin of small hepatocyte-like progenitor in retrorsine-treated ratsPichard, V. / Ferry, N. et al. | 2008
- 369
-
Cells of origin of small hepatocyte-like progenitor cells in the retrorsine model of rat liver injury and regenerationHunter Best, D. / Coleman, W. B. et al. | 2008
- 371
-
Endogenous heparinoids contribute to coagulopathy in patients with liver diseaseSenzolo, M. / Riddell, A. / Tuddenham, E. / Burroughs, A. K. et al. | 2008
- 372
-
Reply to: Endogenous heparinoids contribute to coagulopathy in patients with liver diseaseTripodi, A. / Mannucci, P. M. et al. | 2008
- 373
-
TIPS in hereditary hemorrhagic telangiectasia: Never say neverChanson, N. / Carbonell, N. / Andreani, T. / Bellaiche, G. / Cluzel, P. / Serfaty, L. / Chazouilleres, O. / Poupon, R. et al. | 2008
- 375
-
Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyriaKong, X. F. / Ye, J. / Gao, D. Y. / Gong, Q. M. / Zhang, D. H. / Lu, Z. M. / Lu, Y. M. / Zhang, X. X. et al. | 2008
- 380
-
Inflammation, HCC and sex: IL-6 in the centre of the trianglePrieto, J. et al. | 2008
- 383
-
Potency of tenofovir in chronic hepatitis B: Mono or combination therapy?Reijnders, J. G. / Janssen, H. L. et al. | 2008
- 387
-
TIPS is a cost effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varicesD'Amico, G. / Luca, A. et al. | 2008
- 391
-
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutationsTan, J. / Degertekin, B. / Wong, S. N. / Husain, M. / Oberhelman, K. / Lok, A. S. et al. | 2008
- 399
-
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis CVidali, M. / Tripodi, M. F. / Ivaldi, A. / Zampino, R. / Occhino, G. / Restivo, L. / Sutti, S. / Marrone, A. / Ruggiero, G. / Albano, E. et al. | 2008
- 407
-
Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shuntBoyer, T. D. / Henderson, J. M. / Heerey, A. M. / Arrigain, S. / Konig, V. / Connor, J. / Abu-Elmagd, K. / Galloway, J. / Rikkers, L. F. / Jeffers, L. et al. | 2008
- 415
-
Effect of chronic b-blockade on QT interval in patients with liver cirrhosisZambruni, A. / Trevisani, F. / Di Micoli, A. / Savelli, F. / Berzigotti, A. / Bracci, E. / Caraceni, P. / Domenicali, M. / Felline, P. / Zoli, M. et al. | 2008
- 422
-
Preventing hypoxia/reoxygenation damage to hepatocytes by p66shc ablation: Up-regulation of anti-oxidant and anti-apoptotic proteinsHaga, S. / Terui, K. / Fukai, M. / Oikawa, Y. / Irani, K. / Furukawa, H. / Todo, S. / Ozaki, M. et al. | 2008
- 433
-
The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycleQiu, G. H. / Salto-Tellez, M. / Ross, J. A. / Yeo, W. / Cui, Y. / Wheelhouse, N. / Chen, G. G. / Harrison, D. / Lai, P. / Tao, Q. et al. | 2008
- 442
-
Differential effects of pyrrolidine dithiocarbamate on TNF-a-mediated liver injury in two different models of fulminant hepatitisLu, J. W. / Wang, H. / Yan-Li, J. / Zhang, C. / Ning, H. / Li, X. Y. / Zhang, H. / Duan, Z. H. / Zhao, L. / Wei, W. et al. | 2008
- 453
-
Integrin avb6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapiesPopov, Y. / Patsenker, E. / Stickel, F. / Zaks, J. / Bhaskar, K. R. / Niedobitek, G. / Kolb, A. / Friess, H. / Schuppan, D. et al. | 2008
- 465
-
Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroidsLouvet, A. / Diaz, E. / Dharancy, S. / Coevoet, H. / Texier, F. / Thevenot, T. / Deltenre, P. / Canva, V. / Plane, C. / Mathurin, P. et al. | 2008
- 471
-
Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL)Chung, C. / Doll, J. A. / Gattu, A. K. / Shugrue, C. / Cornwell, M. / Fitchev, P. / Crawford, S. E. et al. | 2008
- 479
-
Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type IaKim, S. Y. / Weinstein, D. A. / Starost, M. F. / Mansfield, B. C. / Chou, J. Y. et al. | 2008
- 486
-
Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in Long-Evans Cinnamon ratsTsubota, A. / Yoshikawa, T. / Nariai, K. / Mitsunaga, M. / Yumoto, Y. / Fukushima, K. / Hoshina, S. / Fujise, K. et al. | 2008
- 494
-
Hepatitis E: An emerging awareness of an old diseasePurcell, R. H. / Emerson, S. U. et al. | 2008
- 504
-
Leukocyte adhesion in the liver: Distinct adhesion paradigm from other organsLee, W. Y. / Kubes, P. et al. | 2008
- 513
-
Iron genes, dysmetabolism and fibrosis in chronic hepatitis CValenti, L. / Dongiovanni, P. / Fargion, S. / Fracanzani, A. L. et al. | 2008
- 514
-
Steatosis, iron and HFE genesGuyader, D. / Deugnier, Y. et al. | 2008
- 515
-
Definition of hepatitis B infection for the best practice in chronic disease and in immunosuppressed patientsMarzano, A. / Alessandria, C. / Rizzetto, M. et al. | 2008
- 516
-
Reply to "Definition of hepatitis B infection for the best practice in chronic disease and in immunosuppressed patients"Thomas, H. et al. | 2008
- 517
-
Evidence of cataplerosis in a patient with neonatal classical galactosemia presenting as citrin deficiencyFeillet, F. / Merten, M. / Battaglia-Hsu, S. F. / Rabier, D. / Kobayashi, K. / Straczek, J. / Brivet, M. / Favre, E. / Gueant, J. L. et al. | 2008
- 523
-
RNAi - A powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycleLupberger, J. / Brino, L. / Baumert, T. F. et al. | 2008
- 526
-
Corrigendum to "Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the `accordion' regimen?" [J Hepatol 47 (2007) 580-587]Marcellin, P. / Heathcote, E. J. / Craxi, A. et al. | 2008
- 529
-
Liver stiffness values in healthy subjects: Implications for clinical practiceCobbold, J. F. / Taylor-Robinson, S. D. et al. | 2008
- 532
-
Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West AfricaBronowicki, J. P. / Abdelmouttaleb, I. / Peyrin-Biroulet, L. / Venard, V. / Khiri, H. / Chabi, N. / Amouzou, E. K. / Barraud, H. / Halfon, P. / Sanni, A. et al. | 2008
- 540
-
Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudineGaia, S. / Barbon, V. / Smedile, A. / Olivero, A. / Carenzi, S. / Lagget, M. / Alessandria, C. / Rizzetto, M. / Marzano, A. et al. | 2008
- 548
-
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: Effect of viremia levels and antiviral treatmentUrbani, S. / Amadei, B. / Tola, D. / Pedrazzi, G. / Sacchelli, L. / Cavallo, M. C. / Orlandini, A. / Missale, G. / Ferrari, C. et al. | 2008
- 559
-
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosisCaraceni, P. / Dazzani, F. / Salizzoni, E. / Domenicali, M. / Zambruni, A. / Trevisani, F. / Bernardi, M. et al. | 2008
- 567
-
Quality of life after liver transplantation. A systematic reviewTome, S. / Wells, J. T. / Said, A. / Lucey, M. R. et al. | 2008
- 578
-
Augmenter of liver regeneration: An important intracellular survival factor for hepatocytesThirunavukkarasu, C. / Wang, L. F. / Harvey, S. A. / Watkins, S. C. / Chaillet, J. R. / Prelich, J. / Starzl, T. E. / Gandhi, C. R. et al. | 2008
- 589
-
NF-kB is a critical regulator of the survival of rodent and human hepatic myofibroblastsWatson, M. R. / Wallace, K. / Gieling, R. G. / Manas, D. M. / Jaffray, E. / Hay, R. T. / Mann, D. A. / Oakley, F. et al. | 2008
- 598
-
Gallbladder disease in patients with primary sclerosing cholangitisSaid, K. / Glaumann, H. / Bergquist, A. et al. | 2008
- 606
-
Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndromeRoulot, D. / Czernichow, S. / Le Clesiau, H. / Costes, J. L. / Vergnaud, A. C. / Beaugrand, M. et al. | 2008
- 614
-
Direct effects of alcohol on hepatic fibrinolytic balance: Implications for alcoholic liver diseaseSeth, D. / Hogg, P. J. / Gorrell, M. D. / McCaughan, G. W. / Haber, P. S. et al. | 2008
- 628
-
Interleukin-10 is a protective factor against diet-induced insulin resistance in liverCintra, D. E. / Pauli, J. R. / Araujo, E. P. / Moraes, J. C. / de Souza, C. T. / Milanski, M. / Morari, J. / Gambero, A. / Saad, M. J. / Velloso, L. A. et al. | 2008
- 638
-
Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathwaysLarter, C. Z. / Yeh, M. M. / Haigh, W. G. / Williams, J. / Brown, S. / Bell-Anderson, K. S. / Lee, S. P. / Farrell, G. C. et al. | 2008
- 648
-
miR-122, a paradigm for the role of microRNAs in the liverGirard, M. / Jacquemin, E. / Munnich, A. / Lyonnet, S. / Henrion-Caude, A. et al. | 2008
- 657
-
Environmental factors as disease accelerators during chronic hepatitis CMallat, A. / Hezode, C. / Lotersztajn, S. et al. | 2008
- 666
-
The function of serotonin within the liverRuddell, R. G. / Mann, D. A. / Ramm, G. A. et al. | 2008
- 676
-
Hepatic microvascular dysfunction and endotoxemia in sepsisFujita, T. et al. | 2008
- 677
-
Reply to: Hepatic microvascular dysfunction and endotoxemia in sepsisRivera, C. A. / Granger, D. N. / Singer, G. et al. | 2008
- 678
-
Significant improvement of portopulmonary hypertension after 1-week terlipressin treatmentKalambokis, G. / Korantzopoulos, P. / Nikas, S. A. / Theodorou, A. / Tsianos, E. V. et al. | 2008
- 681
-
Gastrin-releasing peptide and pruritus: More than just scratching the surfaceSwain, M. G. et al. | 2008
- 684
-
Corrigendum to "Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma" [J Hepatol 46 (2007) 840-848]Semela, D. / Piguet, A. C. / Kolev, M. / Schmitter, K. / Hlushchuk, R. / Djonov, V. / Stoupis, C. / Dufour, J. F. et al. | 2008
- 687
-
Combination therapy for chronic hepatitis B: Ready for prime time?Jacobson, I. M. et al. | 2008
- 692
-
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitisSilveira, M. G. / Lindor, K. D. et al. | 2008
- 695
-
Tenth Forum on Liver Transplantation Are HIV-infected patients candidates for liver transplantation?Clavien, P. A. et al. | 2008
- 697
-
Are HIV-infected patients candidates for liver transplantation?Samuel, D. / Weber, R. / Stock, P. / Duclos-Vallee, J. C. / Terrault, N. et al. | 2008
- 708
-
Hepatic gene expression and prediction of therapy response in chronic hepatitis C patientsSelzner, N. / Chen, L. / Borozan, I. / Edwards, A. / Heathcote, E. J. / McGilvray, I. et al. | 2008
- 714
-
96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis BHui, C. K. / Zhang, H. Y. / Bowden, S. / Locarnini, S. / Luk, J. M. / Leung, K. W. / Yueng, Y. H. / Wong, A. / Rousseau, F. / Yuen, K. Y. et al. | 2008
- 721
-
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis CRomero-Gomez, M. / Fernandez-Rodriguez, C. M. / Andrade, R. J. / Diago, M. / Alonso, S. / Planas, R. / Sola, R. / Pons, J. A. / Salmeron, J. / Barcena, R. et al. | 2008
- 728
-
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis BSung, J. J. / Lai, J. Y. / Zeuzem, S. / Chow, W. C. / Heathcote, E. J. / Perrillo, R. P. / Brosgart, C. L. / Woessner, M. A. / Scott, S. A. / Gray, D. F. et al. | 2008
- 736
-
The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapyKurosaki, M. / Matsunaga, K. / Hirayama, I. / Tanaka, T. / Sato, M. / Komatsu, N. / Umeda, N. / Hosokawa, T. / Ueda, K. / Tsuchiya, K. et al. | 2008
- 743
-
Occult hepatitis B virus in liver tissue of individuals without hepatic diseaseRaimondo, G. / Navarra, G. / Mondello, S. / Costantino, L. / Colloredo, G. / Cucinotta, E. / Di Vita, G. / Scisca, C. / Squadrito, G. / Pollicino, T. et al. | 2008
- 747
-
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failureVillet, S. / Pichoud, C. / Billioud, G. / Barraud, L. / Durantel, S. / Trepo, C. / Zoulim, F. et al. | 2008
- 756
-
Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy studyRodriguez-Torres, M. / Govindarajan, S. / Sola, R. / Clumeck, N. / Lissen, E. / Pessoa, M. / Buggisch, P. / Main, J. / DePamphilis, J. / Dieterich, D. T. et al. | 2008
- 765
-
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study - ANRS HC02Cacoub, P. / Carrat, F. / Bedossa, P. / Lambert, J. / Penaranda, G. / Perronne, C. / Pol, S. / Halfon, P. et al. | 2008
- 774
-
Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled studyTerg, R. / Fassio, E. / Guevara, M. / Cartier, M. / Longo, C. / Lucero, R. / Landeira, C. / Romero, G. / Dominguez, N. / Munoz, A. et al. | 2008
- 780
-
Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/b-catenin signaling pathway in hepatocellular carcinoma cellsKim, M. / Lee, H. C. / Tsedensodnom, O. / Hartley, R. / Lim, Y. S. / Yu, E. / Merle, P. / Wands, J. R. et al. | 2008
- 792
-
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effectiveCullen, S. N. / Rust, C. / Fleming, K. / Edwards, C. / Beuers, U. / Chapman, R. W. et al. | 2008
- 801
-
2-Oxoglutarate-dependent oxygenases control hepcidin gene expressionBraliou, G. G. / Verga Falzacappa, M. V. / Chachami, G. / Casanovas, G. / Muckenthaler, M. U. / Simos, G. et al. | 2008
- 811
-
Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography studyBuonamico, P. / Suppressa, P. / Lenato, G. M. / Pasculli, G. / D'Ovidio, F. / Memeo, M. / Scardapane, A. / Sabba, C. et al. | 2008
- 821
-
Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosisLackner, C. / Gogg-Kamerer, M. / Zatloukal, K. / Stumptner, C. / Brunt, E. M. / Denk, H. et al. | 2008
- 829
-
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver diseaseChalasani, N. / Wilson, L. / Kleiner, D. E. / Cummings, O. W. / Brunt, E. M. / Unalp, A. et al. | 2008
- 835
-
Non-invasive evaluation of liver fibrosis using transient elastographyCastera, L. / Forns, X. / Alberti, A. et al. | 2008
- 848
-
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinomaLencioni, R. / Piscaglia, F. / Bolondi, L. et al. | 2008
- 858
-
Experimental models of hepatocellular carcinomaNewell, P. / Villanueva, A. / Friedman, S. L. / Koike, K. / Llovet, J. M. et al. | 2008
- 880
-
Implementing non-invasive markers for liver fibrosis in clinical practiceSebastiani, G. / Alberti, A. et al. | 2008
- 881
-
Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis CLeroy, V. / Zarski, J. P. et al. | 2008
- 884
-
Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterationsZucman-Rossi, J. et al. | 2008
- 889
-
Building a liver disease policy in the European UnionPawlotsky, J. M. et al. | 2008
- 892
-
Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: Which method should be used?Degertekin, B. / Lok, A. S. et al. | 2008
- 895
-
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic responseBaldick, C. J. / Eggers, B. J. / Fang, J. / Levine, S. M. / Pokornowski, K. A. / Rose, R. E. / Yu, C. F. / Tenney, D. J. / Colonno, R. J. et al. | 2008
- 903
-
Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitisKaplan, D. E. / Ikeda, F. / Li, Y. / Nakamoto, N. / Ganesan, S. / Valiga, M. E. / Nunes, F. A. / Rajender Reddy, K. / Chang, K. M. et al. | 2008
- 914
-
Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replicationBroering, R. / Wu, J. / Meng, Z. / Hilgard, P. / Lu, M. / Trippler, M. / Szczeponek, A. / Gerken, G. / Schlaak, J. F. et al. | 2008
- 923
-
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-upYatsuji, H. / Suzuki, F. / Sezaki, H. / Akuta, N. / Suzuki, Y. / Kawamura, Y. / Hosaka, T. / Kobayashi, M. / Saitoh, S. / Arase, Y. et al. | 2008
- 932
-
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-a2a/ribavirin therapyPugnale, P. / Herrmann, E. / Neumann, A. U. / Pawlotsky, J. M. / Schalm, S. W. / Ferrari, C. / Homburger, Y. / Zeuzem, S. / Negro, F. et al. | 2008
- 939
-
Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort studyCard, T. R. / Solaymani-Dodaran, M. / West, J. et al. | 2008
- 945
-
Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosisStadlbauer, V. / Mookerjee, R. P. / Hodges, S. / Wright, G. A. / Davies, N. A. / Jalan, R. et al. | 2008
- 952
-
Critical role of CD44 in hepatotoxin-mediated liver injuryKimura, K. / Nagaki, M. / Kakimi, K. / Saio, M. / Saeki, T. / Okuda, Y. / Kuwata, K. / Moriwaki, H. et al. | 2008
- 962
-
Vascular endothelial growth factor promotes proliferation and function of hepatocyte-like cells in embryoid bodies formed from mouse embryonic stem cellsFujimori, H. / Asahina, K. / Shimizu-Saito, K. / Ikeda, R. / Tanaka, Y. / Teramoto, K. / Morita, I. / Teraoka, H. et al. | 2008
- 974
-
Quantification of liver perfusion with [15O]H2O-PET and its relationship with glucose metabolism and substrate levelsSlimani, L. / Kudomi, N. / Oikonen, V. / Jarvisalo, M. / Kiss, J. / Naum, A. / Borra, R. / Viljanen, A. / Sipila, H. / Ferrannini, E. et al. | 2008
- 983
-
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxinBergheim, I. / Weber, S. / Vos, M. / Kramer, S. / Volynets, V. / Kaserouni, S. / McClain, C. J. / Bischoff, S. C. et al. | 2008
- 993
-
Fructose consumption as a risk factor for non-alcoholic fatty liver diseaseOuyang, X. / Cirillo, P. / Sautin, Y. / McCall, S. / Bruchette, J. L. / Diehl, A. M. / Johnson, R. J. / Abdelmalek, M. F. et al. | 2008
- 1000
-
Thrombocytopenia associated with chronic liver diseaseAfdhal, N. / McHutchison, J. / Brown, R. / Jacobson, I. / Manns, M. / Poordad, F. / Weksler, B. / Esteban, R. et al. | 2008
- 1008
-
Allogeneic hematopoietic cell transplant in HCV-infected patientsPeffault de Latour, R. / Ribaud, P. / Robin, M. / Valla, D. / Marcellin, P. / Socie, G. / Asselah, T. et al. | 2008
- 1018
-
Incidence of adrenal dysfunction in cirrhosisO'Beirne, J. / Burroughs, A. K. et al. | 2008
- 1018
-
Adrenal insufficiency and liver disease - Re-searchMcCaughan, G. W. et al. | 2008
- 1019
-
Medical procedures as a risk factor for HCV infection in developed countries: Do we neglect a significant problem in medical care?Deterding, K. / Wiegand, J. / Gruner, N. / Wedemeyer, H. et al. | 2008
- 1020
-
Nosocomial acquisition of the hepatitis C virusForns, X. / Sanchez-Tapias, J. M. / Bruguera, M. et al. | 2008
- 1022
-
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipientsLevicnik-Stezinar, S. / Rahne-Potokar, U. / Candotti, D. / Lelie, N. / Allain, J. P. et al. | 2008
- 1026
-
Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: Significant clinical improvement during tamoxifen treatmentLenci, I. / Angelico, M. / Tisone, G. / Orlacchio, A. / Palmieri, G. / Pinci, M. / Bombardieri, R. / Curatolo, P. et al. | 2008
- 1030
-
Eltrombopag: An effective remedy for thrombocytopaenia?Mondelli, M. U. et al. | 2008
- 1032
-
The gut-liver-axis: Endotoxemia, inflammation, insulin resistance and NASHSiebler, J. / Galle, P. R. / Weber, M. M. et al. | 2008
- I
-
Guide for Authors| 2008
- iii
-
Call for EASL Treasurer| 2008
- III
-
Volume Contents| 2008
- ix
-
Contents| 2008
- S2
-
Hepatitis B: Reflections on the current approach to antiviral therapyZoulim, F. / Perrillo, R. et al. | 2008
- S4
-
5 EXHAUSTION AND FUNCTIONAL RESTORATION OF INTRAHEPATIC HBV-SPECIFIC T CELLS IN CHRONIC HEPATITIS BFisicaro, P. / Valdatta, C. / Boni, C. / Zerbini, A. / Giuberti, T. / Schivazappa, S. / Missale, G. / Ferrari, C. et al. | 2008
- S6
-
10 RIBAVIRIN CONCENTRATION AT WEEK FOUR IS AN INDEPENDEND PREDICTOR FOR SUSTAINED VIROLOGICAL RESPONSE AFTER TREATMENT OF HEPATITIS C GENOTYPE 2/3 (NORDYNAMIC TRIAL)Christensen, P. B. / Alsio, A. A. / Buhl, M. R. / Farkkila, M. / Morch, K. / Sangfelt, P. / Lagging, M. / Norkrans, G. / Pedersen, C. et al. | 2008
- S7
-
13 POTENTIAL NEGATIVE IMPACT OF AGING ON HEPATOCARCINOGENESIS AFTER ANTI-VIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C AND BENEFIT OF VIRAL ERADICATION BY PEG-INTERFRON/RIBAVIRIN TREATMENTAsahina, Y. / Izuni, N. / Hirayama, I. / Sato, M. / Yasui, Y. / Tanaka, T. / Komatsu, N. / Umeda, N. / Hosokawa, T. / Ueda, K. et al. | 2008
- S8
-
16 TRANSITORY REPLICATION OF HCV (JFH1 STRAIN) IN HEPG2 AND HEPA-RG CELLS: CONTRIBUTION OF THE MODE OF GENOME DELIVERY AND MODULATION OF INNATE IMUNE RESPONSESDurantel, D. / Alotte, C. / Lucifora, J. / Maire, M. / Cosset, F. L. / Bartosch, B. / Zoulim, F. et al. | 2008
- S12
-
26 90Y RADIOEMBOLIZATION IN HCC PATIENTS WITH AND WITHOUT PORTAL VEIN THROMBOSIS: LONG-TERM SURVIVALKulik, L. M. / Ibrahim, S. M. / Lewandowski, R. J. / Abecassis, M. / Sato, K. T. / Ryu, R. K. / Salem, R. et al. | 2008
- S14
-
31 VALIDATION OF A DIAGNOSTIC BIOMARKER PANEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)Younossi, Z. M. / Jarrar, M. / Nugent, C. / Randhawa, M. / Afendy, M. / Stepanova, M. / Afendy, A. / Rafiq, N. / Goodman, Z. / Chandhoke, V. et al. | 2008
- S15
-
34 PROSPECTIVE SCREENING OF INFECTION IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS TREATED WITH STEROIDS: EARLY RESPONSE TO THERAPY IS THE KEY FACTORLouvet, A. / Dharancy, S. / Boitard, J. / Wartel, F. / Canva-Delcambre, V. / Deltenre, P. / Mathurin, P. et al. | 2008
- S16
-
37 IMMUNE RESPONSES TOWARD OXIDATIVE STRESS-DERIVED ANTIGENS SUSTAIN INFLAMMATION IN ALCOHOLIC LIVER DISEASEVidali, M. / Hietala, J. / Occhino, G. / Ivaldi, A. / Sutti, S. / Niemela, O. / Albano, E. et al. | 2008
- S19
-
45 TUMOR NECROSIS FACTOR-ALPHA INDUCES HEPATOCYTE SURVIVAL BY DOWNREGULATION OF THE DE-UBIQUITINATING ENZYME USP2Haimerl, F. / Sass, G. / Tiegs, G. et al. | 2008
- S20
-
48 KNOCKDOWN OF NK RELATED KILLING-IMMUNOGLOBULIN RECEPTORS DECREASE HEPATIC FIBROSISMuhanna, N. / Azzeh, M. / Doron, S. / Safadi, R. et al. | 2008
- S20
-
Novel advancements in the management of hepatocellular carcinoma in 2008Llovet, J. M. / Bruix, J. et al. | 2008
- S21
-
50 24-NOR-URSODEOXYCHOLIC ACID AS NOVEL THERAPEUTIC STRATEGY FOR INFLAMMATION-INDUCED LIVER FIBROSIS IN A MURINE MODEL OF SCHISTOSOMA MANSONI INFECTIONSombetzki, M. / Fickert, P. / Loebermann, M. / Holtfreter, M. / Fuchsbichler, A. / Gumhold, J. / Silbert, D. / Langner, C. / Reisinger, E. C. / Trauner, M. et al. | 2008
- S22
-
53 ATTENUATED INFLAMMATORY RESPONSE IN FIBROTIC LIVERS OF MICE LACKING THE C-REL SUBUNIT OF NF-KBElsharkawy, A. M. / Gieling, R. G. / Oakley, F. / Kendall, T. / Burt, A. D. / Mann, D. A. et al. | 2008
- S27
-
61 FACTORS INFLUENCING PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS OF THE 3-YEAR T2S-918-HCV STUDY WITH HCVE1 THERAPEUTIC VACCINATIONWedemeyer, H. / Mazur, W. / Nevens, F. / Horsmans, Y. / Adler, M. / Blum, H. / Inglot, M. / Gerken, G. / Janczewska, E. / Roskams, T. et al. | 2008
- S28
-
64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDYReesink, H. / Verloes, R. / Abou Farha, K. / Van Vliet, A. / Weegink, C. / van t Klooster, G. / Aharchi, F. / Marien, K. / Van Remoortere, P. / de Kock, H. et al. | 2008
- S30
-
69 VIRION HALF-LIFE IN CHRONIC HEPATITIS B INFECTION IS STRONGLY CORRELATED WITH VIRAL LOADDandri, M. / Murray, J. M. / Luetgehetmann, M. / Volz, T. / Lohse, A. / Petersen, J. et al. | 2008
- S34
-
78 TUMOR PROMOTING EFFECT OF HCV TRANSGENE IN INFLAMMATION-ASSOCIATED HCC IS DEPENDENT ON HOST GENETIC BACKGROUNDKlopstock, N. / Katzenellenbogen, M. / Pappo, O. / Olam, D. / Mizrahi, L. / Domany, E. / Galun, E. / Goldenberg, D. et al. | 2008
- S35
-
81 COMBINED HEPATOCHOLANGIOCARCINOMAS IN RATS DEVELOP FROM BONE MARROW-DERIVED LIVER STEM CELLS IN RATSPiscaglia, A. C. / Shupe, T. D. / Novi, M. / Campanale, M. C. / Gasbarrini, A. / Petersen, B. E. et al. | 2008
- S38
-
88 EFFECT OF CANNABINOID CB1-RECEPTOR ANTAGONISM ON ASCITIC DECOMPENSATION OF RATS WITH PREASCITIC CIRRHOSISDomenicali, M. / Caraceni, P. / Pertosa, A. M. / Giannone, F. / Principe, A. / Zambruni, A. / Trevisani, F. / Bernardi, M. et al. | 2008
- S38
-
The challenges in primary sclerosing cholangitis - Aetiopathogenesis, autoimmunity, management and malignancyWeismuller, T. J. / Wedemeyer, J. / Kubicka, S. / Strassburg, C. P. / Manns, M. P. et al. | 2008
- S39
-
91 MORBIDITY AND MORTALITY FOLLOWING CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY IN PATIENTS WITH CIRRHOSIS: A POPULATION-BASED STUDYShaheen, A. A. / Kaplan, G. G. / Myers, R. P. et al. | 2008
- S40
-
94 ADIPONECTIN-DEPENDENT ACTIVATION OF AMPK, BUT NOT OF PPARA, IS IMPLICATED IN THE PREVENTIVE EFFECT OF PIOGLITAZONE ON STEATOHEPATITISda Silva Morais, A. / Lebrun, V. / Abarca-Quinones, J. / Brichard, S. / Hue, L. / Guigas, B. / Viollet, B. / Leclercq, I. A. et al. | 2008
- S42
-
99 BILE ACIDS PREVENT FRUCTOSE-INDUCED HEPATIC STEATOSISVolynets, V. / Weber, S. / Wagnerberger, S. / Bischoff, S. C. / Bergheim, I. et al. | 2008
- S48
-
109 CORRELATION OF LIVER "COLLAGEN PROPORTIONATE AREA" BY COMPUTER ASSISTED IMAGE ANALYSIS AND HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATIONCalvaruso, V. / Standish, R. / Manousou, P. / Maimone, S. / Patch, D. / OBeirne, J. / Pleguezuelo, M. / Xirouchakis, I. / Guerrini, G. P. / Dhillon, A. P. et al. | 2008
- S49
-
112 THE VARIANT MANNOSE-BINDING LECTIN GENOTYPE OF THE DONOR INFLUENCES THE EVOLUTION OF LIVER TRANSPLANTATIONBalderramo, D. C. / Cervera, C. / Pascal, M. / Prieto, J. / Suarez, B. / Fuster, F. / Linares, L. / Moreno, A. / Lozano, F. / Navasa, M. et al. | 2008
- S51
-
117 PROSPECTIVE STUDY OF NK CELL PHENOTYPE IN RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTVarchetta, S. / Oliviero, B. / Donato, F. / Agnelli, F. / Rossi, G. / Rigamonti, C. / Colombo, M. / Paudice, E. / Mavilio, D. / Mondelli, M. U. et al. | 2008
- S52
-
120 HEPATITIS C VIRUS-INDUCED SECRETION OF INFLAMMATORY CHEMOKINES PREFERENTIALLY RECRUIT NKG2A EXPRESSING CD8+ T CELLSNattermann, J. / Sherzada, R. / Iwan, A. / Bogen, D. / Niederle, I. M. / Schulte, D. / Mertens, E. / Nischalke, H. D. / Kraemer, B. / Sauerbruch, T. et al. | 2008
- S54
-
125 SIDE CHAIN MODIFIED BILE ACIDS MODULATE ENDOPLASMIC RETICULUM STRESS IN MDR2-/- MICE IN VIVO AND BILE DUCT EPITHELIAL CELLS IN VITROMoustafa, T. / Halilbasic, E. / Fickert, P. / Fuchsbichler, A. / Gumhold, J. / Silbert, D. / Denk, H. / Trauner, M. et al. | 2008
- S55
-
128 BIPHASIC YB-1 ACTIVATION BY DIFFERENT MECHANISMS MEDIATES HEPATIC MRP2 SUPPRESSION AND MMP-2 INDUCTION BY PROINFLAMMATORY SIGNALSMartin, I. V. / Mertens, P. R. / Frye, B. / Strauch, S. / Rauen, T. / Trautwein, C. / Geier, A. et al. | 2008
- S56
-
131 EVIDENCES FOR A ROLE OF CANALICULAR BCRP/ABCG2 ON SULPHATED BILE ACID SECRETIONBlazquez, A. G. / Briz, O. / Romero, M. R. / Rosales, R. / Martinez-Becerra, P. / Jimenez, F. / Serrano, M. A. / Marin, J. J. et al. | 2008
- S58
-
Hot topics in liver transplantation: Organ allocation - extended criteria donor - living donor liver transplantationMullhaupt, B. / Dimitroulis, D. / Gerlach, J. T. / Clavien, P. A. et al. | 2008
- S58
-
136 REDOX-SENSITIVE GSK-3BETA INHIBITION AND LATE VEGF RELEASE MEDIATE HYPOXIA-DEPENDENT EPITHELIAL-MESENCHYMAL TRANSITION AND INCREASED INVASIVENESS IN HUMAN HEPG2 CELLSCannito, S. / Novo, E. / Compagnone, A. / Valfre di Bonzo, L. / Busletta, C. / Zamara, E. / Bandino, A. / Cravanzola, C. / Bravoco, V. / Colombatto, S. et al. | 2008
- S59
-
139 SEROTONIN 2B RECEPTOR: A NOVEL NEGATIVE REGULATOR OF LIVER GROWTHEbrahimkhani, M. R. / Maroteaux, L. / Mann, D. A. / Oakley, F. et al. | 2008
- S65
-
149 INSULIN-LIKE GROWTH FACTOR-I (IGF-I) REDUCES THE IMPACT OF AGE IN OXIDATIVE LIVER DAMAGE AND RESTORES INSULIN RESISTANCE AND LIPID METABOLISMGarcia-Fernandez, M. / Puche, J. E. / Delgado, G. / Gonzalez-Baron, S. / Castilla-Cortazar, I. et al. | 2008
- S67
-
154 DIFFERENTIAL EFFECT OF CALCINEURIN INHIBITORS, TACROLIMUS AND CYCLOSPORINE A, ON INTERFERON INDUCED ANTI-VIRAL PROTEIN IN HUMAN HEPATOCYTE CELLIchikawa, T. / Nakao, K. / Miyaaki, H. / Shibata, H. / Takashita, S. / Eguchi, S. / Takatsuki, M. / Ikeda, M. / Kato, N. / Kanematsu, T. et al. | 2008
- S68
-
The management of portal hypertension: Rational basis, available treatments and future optionsBosch, J. / Berzigotti, A. / Garcia-Pagan, J. C. / Abraldes, J. G. et al. | 2008
- S68
-
157 MYCOPHENOLIC ACID INTERFERES WITH TRAFFICKING PROPERTIES OF HUMAN BLOOD MYELOID DENDRITIC CELLSCicinnati, V. R. / Hou, J. / Lindemann, M. / Klein, C. G. / Gerken, G. / Beckebaum, S. et al. | 2008
- S69
-
160 SELECTIVE ACTIVATION OF PROTECTIVE NF-KB DEPENDENT GENES BY S-ADENOSYLMETHIONINE REDUCES ISCHEMIA/REPERFUSION INJURY IN MOUSE LIVERLlacuna, L. / Morales, A. / Fernandez-Checa, J. C. et al. | 2008
- S71
-
166 INSULIN-LIKE GROWTH FACTOR I (IGF-I) RESTORES LIVER MITOCHONDRIAL DYSFUNCTION IN AGING RATSPuche, J. E. / Garcia-Fernandez, M. / Rioja, J. / Gonzalez-Baron, S. / Castilla-Cortazar, I. et al. | 2008
- S72
-
169 MODULATION OF PRO- AND ANTI-REGENERATIVE CYTOKINES AND TRANSCRIPTION FACTORS BY TLR STIMULATION IN NON-PARENCHYMAL LIVER CELLSSzczeponek, A. / Sowa, J. P. / Schlaak, J. F. et al. | 2008
- S73
-
172 ORAL ANTIVIRAL THERAPY WITHOUT LONG TERM MAINTENANCE HEPATITIS B IMMUNOGLOBULIN TO PREVENT HEPATITIS B RECURRENCE IN LIVER TRANSPLANT PATIENTSAhn, J. / Dodson, S. F. / Cohen, S. M. et al. | 2008
- S75
-
177 MAINTENANCE REGIME WITH TACROLIMUS <= 1 MG/DAY AFTER LIVER TRANSPLANTATION IN ADULTS: EVALUATION FROM 5 TO 18 YEARS AFTER THE FIRST TRANPLANTATIONBernuau, J. R. / Pironti, A. / Francoz, C. / Plessier, A. / Paradis, V. / Dondero, F. / Sommacale, D. / Belghiti, J. / Valla, D. / Durand, F. et al. | 2008
- S76
-
180 CAUSES AND THERAPY OF ANEMIA AFTER LIVER TRANSPLANTATION (OLT)Bonacini, M. / Inductivo-Yu, I. / Cummins, A. / Bishop, R. / Devole, N. et al. | 2008
- S77
-
183 MELD CLASS AND LONG-TERM SURVIVAL BENEFIT OF LIVER TRANSPLANTATION: AN INTENTION-TO-TREAT ANALYSISAvolio, A. W. / Siciliano, M. / Agnes, S. / Gasbarrini, A. / Caracciolo, G. / Barbarino, R. / Annicchiarico, B. E. / Castagneto, M. et al. | 2008
- S78
-
186 VIROLOGICAL AND CLINICAL SETTINGS ASSOCIATED WITH HBV SEROREVERSION AND REACTIVATION IN HIV-1 INFECTED PATIENTS IN SOUTH-EASTERN FRANCEColson, P. / Motte, A. / Menard, A. / Moreau, J. / Ravaux, I. / Poizot-Martin, I. / Benhaim, S. / Mokhtari, S. / Gerolami, R. / Tamalet, C. et al. | 2008
- S79
-
189 EFFECT OF IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE, ICL670) OR DEFEROXAMINE ON HEPATOCELLULAR INFLAMMATION AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIADeugnier, Y. / Turlin, B. / Ropert-Bouchet, M. / Rabault, B. / Brissot, P. et al. | 2008
- S80
-
191 EVOLUTION AFTER LISTING AND RESULTS OF LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN HIV/HCV AND HIV/HBV COINFECTED PATIENTSVibert, E. / Adam, R. / Tralhao, J. G. / Azoulay, D. / Castaing, D. / Samuel, D. / Duclos-Vallee, J. C. et al. | 2008
- S81
-
194 RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CHRONIC REJECTION DURING ANTIVIRAL THERAPY OF POST-TRANSPLANT RECURRENT HEPATITIS C: A PROSPECTIVE STUDYFernandez, I. / Ulloa, E. / Jimenez, C. / Colina, F. / Gimeno, A. / Abradelo, M. / Munoz, R. / Manzano, M. L. / Castellano, G. / Meneu, J. C. et al. | 2008
- S84
-
202 HIGH MORTALITY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) PLACEMENT IN LIVER TRANSPLANT RECIPIENTSGraziadei, I. W. / Finkenstedt, A. / Nachbaur, K. / Jaschke, W. / Mark, W. / Margreiter, R. / Vogel, W. et al. | 2008
- S87
-
211 OUTCOME OF TAIWANESE PATIENTS UNDERGOING CADAVERIC LIVER TRANSPLANTATION IN CHINA - THE EXPERIENCE OF TAIPEI VETERANS GENERAL HOSPITALKuo, W. T. / Hsia, C. Y. / Loong, C. C. / Wu, C. W. / Lui, W. Y. et al. | 2008
- S89
-
216 ESTIMATED GLOMERULAR FILTRATION RATE MAY BE SUPERIOR TO CREATININE IN PREDICTING DEATH ON THE WAITING LIST FOR LIVER TRANSPLANTATIONLeithead, J. A. / Ferguson, J. W. / Hayes, P. C. et al. | 2008
- S90
-
219 THE RELATIONSHIP BETWEEN SEXUAL DYSFUNCTION (SD) AND QUALITY OF LIFE (QOL) IN MALE AFTER LIVER TRANSPLANTATIONMasier, A. / Salonia, A. / Germani, G. / Gambato, M. / De Martin, E. / Senzolo, M. / Russo, F. P. / Boccagni, P. / Cillo, U. / Sturniolo, G. C. et al. | 2008
- S91
-
222 CARDIOVASCULAR EVENTS IN ORTHOTOPIC LIVER TRANSPLANT ASSESSMENT CANDIDATES: AN ANALYSIS OF RISK FACTORSMcAvoy, N. C. / Briody, L. J. / McKillop, G. / Newby, D. E. / Hayes, P. C. et al. | 2008
- S92
-
224 INTEREST OF FIBROTEST-ACTITEST (FT-AT) IN THE FOLLOW-UP OF LIVER TRANSPLANTED (LT) PATIENTS: A PILOT STUDYHamelet, E. / Munteanu, M. / Thibault, V. / Imbert-Bismut, F. / Morra, R. / Charlotte, F. / Vezinnet, C. / Poynard, T. / Hannoun, L. / Hainque, B. et al. | 2008
- S93
-
Pathogenesis and management of hepatorenal syndrome in patients with cirrhosisAngeli, P. / Merkel, C. et al. | 2008
- S94
-
230 INTRAVENOUS SUBSTANCE USE AND THE OUTCOME OF LIVER TRANSPLANTATION FOR CHRONIC HEPATITIS CRobaeys, G. / Nevens, F. / Van Eyken, P. / Starkel, P. / Colle, I. / Bruckers, L. / Van Ranst, M. / Buntinx, F. et al. | 2008
- S95
-
233 EFFECT OF ANTIVIRAL TREATMENT, RETREATMENT, AND STAGE OF FIBROSIS ON PROGRESSION OF LIVER FIBROSIS, AND OUTCOME AFTER LIVER TRANSPLANTATIONRoche, B. / Sebagh, M. / Acanfora, A. M. / Antonini, T. / Roque-Afonso, A. M. / Saliba, F. / Duclos-Vallee, J. C. / Delvart, V. / Castaing, D. / Samuel, D. et al. | 2008
- S96
-
236 ACUTE LIVER FAILURE IN PREGNANCY: ETIOLOGICAL AND CLINICAL PROFILESomani, A. / Jain, A. K. / Dixit, V. K. / Somani, S. et al. | 2008
- S97
-
239 POSTOPERATIVE OUTCOME AFTER HEPATECTOMY CAN BE PREDICTED USING A NEW BEDSIDE TEST FOR MAXIMAL LIVER FUNCTION CAPACITYStockmann, M. / Lock, J. / Riecke, B. / Heyne, K. / Martus, P. / Fricke, M. / Lehmann, S. / Niehues, S. / Schwabe, M. / Lemke, A. J. et al. | 2008
- S98
-
242 HCC RECURRENCE AFTER LIVER TRANSPLANTATION: ROLE OF IMMUNOSUPPRESSION WITH CALCINEURIN INHIBITORSVivarelli, M. / Cucchetti, A. / La Barba, G. / Cescon, M. / Del Gaudio, M. / Ercolani, G. / Lauro, A. / Ravaioli, M. / Grazi, G. L. / Pinna, A. D. et al. | 2008
- S100
-
247 REDUCED COX-RELATED PRODUCTION OF VASOCONSTRICTORS AND NOT NO-MEDIATED VASODILATION IS A COMMON MECHANISM OF VASCULAR HYPOREACTIVITY IN DIFFERENT MODELS OF PORTAL HYPERTENSION IN RATSVerlinden, W. / Brosius, I. / Van Marck, E. / Herman, A. / Pelckmans, P. / Michielsen, P. / Francque, S. et al. | 2008
- S101
-
250 THE INCREASED SERUM PIGMENT EPITHELIUMDERIVED FACTOR, A POTENT ENDOGENOUS ANGIOGENESIS INHIBITOR IN LIVER CIRRHOSISJaroszewicz, J. / Rogalska, M. / Flisiak, R. et al. | 2008
- S102
-
253 COMPARATIVE STUDY OF TRANSIENT ELASTOMETRY AND HEPATIC VEIN TRANSIT TIME OF A ULTRASOUND CONTRAST AGENT IN FIBROSING LIVER DISEASEMarion, D. / Bailly, F. / Maynard, M. / Scoazec, J. Y. / Miailhes, P. / Pradat, P. / Lapras, V. / Trepo, C. et al. | 2008
- S103
-
256 ONE MONTH CAFETERIA DIET INDUCES NAFLD AND LIVER SINUSOIDAL ENDOTHELIAL DYSFUNCTION IN RATSAbraldes, J. G. / Pasarin, M. / Rodriguez-Vilarrupla, A. / Matei, V. / Gracia-Sancho, J. / Garcia-Pagan, J. C. / Bosch, J. et al. | 2008
- S104
-
Non-alcoholic fatty liver disease: The mist gradually clearsde Alwis, N. M. / Day, C. P. et al. | 2008
- S106
-
264 DEFICIENCY IN PLACENTAL GROWTH FACTOR CAUSES A DECREASED PORTO-SYSTEMIC COLLATERAL VESSEL FORMATION IN PORTAL HYPERTENSIVE MICEVan Steenkiste, C. / Geerts, A. / Vanheule, E. / Van Vlierberghe, H. / De Vos, F. / Carmeliet, P. / De Vos, M. / Colle, I. et al. | 2008
- S107
-
267 GASTRIC MYOELECTRICAL ACTIVITY IN PATIENTS WITH LIVER CIRRHOSISVladimirov, G. B. / Boyadzhieva, M. V. / Sulejman, S. / Ivanova, R. / Petrova, J. / Mateva, L. et al. | 2008
- S111
-
278 BLOOD GLUCOSE AND GLYCOSYLATED HAEMOGLOBIN ARE INSENSITIVE DIAGNOSTIC INDICATORS OF GLUCOSE INTOLERANCE IN PATIENTS WITH CIRRHOSISRhee, K. J. / Chandarana, K. A. / Ruparelia, R. / Woolman, E. / Kanagalingam, S. / Thomas, M. / Morgan, M. Y. et al. | 2008
- S113
-
Iron and the liver: Update 2008Deugnier, Y. / Brissot, P. / Loreal, O. et al. | 2008
- S113
-
283 INDEPENDENT PREDICTORS OF DISCORDANCE BETWEEN TRANSIENT ELASTOGRAPHY (TE) AND LIVER BIOPSY (LB)Fraquelli, M. / Rigamonti, C. / Conte, D. / Casazza, G. / Donate, M. F. / Rumi, M. G. / Lampertico, P. / Ronchi, G. / Colombo, M. et al. | 2008
- S114
-
286 VON WILLEBRAND FACTOR PREDICTS CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSISHomoncik, M. / Ferlitsch, A. / Reiberger, T. / Ulbrich, G. / Gangl, A. / Peck-Radosavljevic, M. et al. | 2008
- S115
-
289 EARLY MEASUREMENT OF HEPATIC VENOUS PRESSURE GRADIENT (HVPG) ACCURATELY PREDICTS TREATMENT FAILURE AND OUTCOME IN PATIENTS WITH ACUTE VARICEAL BLEEDINGJha, S. K. / Kumar, A. / Sharma, P. / Sharma, B. C. / Sarin, S. K. et al. | 2008
- S116
-
292 A RANDOMIZED PILOT TRIAL OF ORAL BRANCHED-CHAIN AMINO ACIDS IN EARLY LIVER CIRRHOSISKawamura, E. / Habu, D. / Iwai, S. / Morikawa, H. / Enomoto, M. / Tamori, A. / Sakaguchi, H. / Kawada, N. / Shiomi, S. et al. | 2008
- S118
-
297 LYING AND STANDING CONTRAST ECHOCARDIOGRAPHY FOR THE DIAGNOSIS OF HEPATOPULMONARY SYNDROME IN PATIENTS UNDERGOING LIVER TRANSPLANTATIONLenci, I. / Steeds, R. / Alvior, A. / Manzia, T. M. / Toti, L. / Sandmann, H. / Edwards, N. / Neuberger, J. et al. | 2008
- S121
-
306 CLINICAL SIGNIFICANCE OF INCREASED SERUM AMINOTRANSFERASE IN BUDD-CHIARI SYNDROMERautou, P. E. / Moucari, R. / Cazals-Hatem, D. / Escolano, S. / Denie, C. / Francoz, C. / Durand, F. / Ozenne, V. / Imbert, A. / Plessier, A. et al. | 2008
- S123
-
311 TERLIPRESSIN AND ALBUMIN IN CIRRHOTIC PATIENTS WITH HEPATORENAL SYNDROME TYPE-1 WITH AND WITHOUT ACTIVE INFECTIONSerrano-Romero, M. / Pascasio, J. M. / Sousa, J. M. / Cayuela, A. / Ferrer, M. T. / Gomez-Navarro, E. / Prieto, J. L. / Sayago, M. / Cabanillas, M. et al. | 2008
- S124
-
Gallstone disease: From genes to evidence-based therapyLammert, F. / Miquel, J. F. et al. | 2008
- S125
-
317 PROGNOSTIC INDICATORS OF SURVIVAL IN COMPENSATED AND DECOMPENSATED STAGES OF LIVER CIRRHOSIS: VALIDATION OF A 4-STAGE CLASSIFICATIONZipprich, A. / Dollinger, M. M. / Garcia-Tsao, G. / Rogowski, S. / Fleig, W. E. et al. | 2008
- S126
-
320 HUMAN CD4+ T CELLS RECOGNIZE AN EPITOPE WITHIN ALPHA-FETOPROTEIN SEQUENCE AND DEVELOP INTO TH3 CELLSAlisa, A. / Boswell, S. / Williams, R. / Behboudi, S. et al. | 2008
- S127
-
323 GENOME-WIDE GENETIC ALTERATIONS IN BILIARY TRACT CANCER ASSOCIATED WITH LIVER FLUKE INFECTIONDachrut, S. / Pairojkul, C. / Chen, X. / Sripa, B. et al. | 2008
- S128
-
326 LEPTIN IS A GROWTH FACTOR FOR CHOLANGIOCARCINOMA: AN IN VIVO EXPERIMENTAL STUDYFava, G. / Alpini, G. / Svegliati-Baroni, G. / Rychlicki, C. / Saccomanno, S. / Trozzi, L. / Candelaresi, C. / Di Sario, A. / Marzioni, M. / Benedetti, A. et al. | 2008
- S130
-
331 C-FOS ACCELERATES HEPATOCYTE SPREADING AND MOTILITY TRIGGERED BY EGF AND TGF-BETA COSTIMULATION THROUGH ERK-MEDIATED UPREGULATION OF PAXILLIN-SERINE178 PHOSPHORYLATIONGuller, M. C. / Andre, J. / Mauviel, A. / Verrecchia, F. / Bernuau, D. et al. | 2008
- S131
-
334 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AGONISTS, PIOGLITAZONE AND PROSTAGLANDIN J2 HAVE PROMINENT ANTINEOPALSTIC EFFECTS AGAINST HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA CELLSShim, J. J. / Kim, B. H. / Jang, J. Y. / Dong, S. H. / Kim, H. J. / Chang, Y. W. / Chang, R. et al. | 2008
- S133
-
339 TARGETING THE HISTONE DEACETYLASE-SIRT1 FOR ANTI-TUMOR THERAPY: INHIBITION OF SIRT1 DOWN-REGULATES HIF-1Laemmle, A. / Vorburger, S. / Keogh, A. / Roh, V. / Candinas, D. / Stroka, D. et al. | 2008
- S134
-
342 TELOMERASE-DEPENDENT CONDITIONALLY REPLICATING ADENOVIRUS (HTERT-AD) EXPRESSING CAREX-PTDS DISPLAYS ENHANCED ONCOLYTIC PROPERTIES IN NONPERMISSIVE TUMORSOhnhaeuser, K. / Woller, N. / Guerlevik, E. / Manns, M. P. / Kubicka, S. / Kuehnel, F. et al. | 2008
- S135
-
345 CK2 CONTRIBUTES TO CELL SURVIVAL IN HEPATOCELLULAR CARCINOMA BY ACTIVATING NFKB AND CONTRIBUTING TO THE WNT SIGNAL TRANSDUCTION PATHWAYSass, G. / Buerbank, S. / Klinger, N. / Ocker, M. / Cheusova, T. / Hashemolhosseini, S. / Papadopoulos, T. / Tiegs, G. et al. | 2008
- S137
-
350 SPONTANEOUS AND PERSISTENT ACTIVATION OF PPAR ALPHA IN HCV CORE PROTEIN TRANSGENIC MICE: IMPLICATIONS FOR HCV-ASSOCIATED HEPATOCARCINOGENESISTanaka, N. / Aoyama, T. et al. | 2008
- S140
-
359 GRADE OF DIFFERENTIATION AND TUMOR CAPSULE PREDICT THE LOCAL THERAPEUTIC RESPONSE OF HEPATOCELLULAR CARCINOMA TO PERCUTANEOUS ETHANOL INJECTION: RESULTS OF A PROSPECTIVE STUDYCastroagudin, J. F. / Molina, E. / Abdulkader, I. / Forteza, J. / Bustamante, M. / Dominguez-Munoz, J. E. / Varo, E. et al. | 2008
- S141
-
362 SHORT-TERM EFFICACY AND SAFETY OF TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA WITH SORAFENIBCastroagudin, J. F. / Molina, E. / Otero, E. / Tome, S. / Lopez, R. / Varo, E. et al. | 2008
- S144
-
371 ATROPINE FOR THE PREVENTION OF CARDIAC DYSRHYTHMIAS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING PERCUTANEOUS ETHANOL INSTILLATION: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALFerlitsch, A. / Schmid, M. / Schmidinger, H. / Homoncik, M. / Pleiner-Duxneuner, J. / Ulbrich, G. / Gangl, A. / Peck-Radosavljevic, M. et al. | 2008
- S145
-
374 EXPRESSION OF THE NUCLEAR FACTOR KAPPA B (NFKB) P50/P65 PROTEINS IN HEPATOCELLULAR CARCINOMA (HCC): LACK OF PREDICTIVE VALUE FOR RESPONSE TO THALIDOMIDE TREATMENTHsu, C. / Chen, L. T. / Chao, Y. / Fan, H. H. / Shen, Y. C. / Cheng, A. L. et al. | 2008
- S146
-
377 ASSOCIATION OF COEXISTENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG) AND ANTI-HBS WITH HEPATOCELLULAR CARCINOMA IN GENOTYPE C HBV INFECTION; A PROSPECTIVE CROSS-SECTIONAL STUDYKim, H. S. / Jang, J. S. / Kim, H. J. / Shin, W. G. / Kim, K. H. / Lee, J. H. / Kim, H. Y. / Hahn, T. H. / Park, S. H. / Park, C. K. et al. | 2008
- S148
-
382 USEFULNESS OF 18F-FDG POSITRON EMISSION TOMOGRAPHY/COMPUTER TOMOGRAPHY IN THE DETECTION OF METASTATIC HEPATOCELLULAR CARCINOMASKim, Y. S. / Park, J. M. / Kim, S. G. / Jang, J. Y. / Kim, W. J. / Cheon, Y. K. / Moon, J. H. / Cho, Y. D. / Kim, H. S. / Lee, M. S. et al. | 2008
- S151
-
390 LONG-TERM PROGNOSIS OF COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA AFTER CURATIVE RESECTIONLee, J. H. / Kim, Y. J. / Park, B. J. / Kim, D. H. / Jung, Y. J. / Yoon, J. H. / Kim, C. Y. / Lee, H. S. et al. | 2008
- S152
-
393 ISCHEMIA MODIFIED ALBUMIN AS A EARLY PREDICTOR OF TREATMENT RESPONSE AFTER TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMAKim, C. W. / Lee, C. D. / Jang, J. W. / Nam, S. W. / Bae, S. H. / Choi, J. Y. / Cho, S. H. / Yoon, S. K. / Yang, J. M. / Choi, S. W. et al. | 2008
- S153
-
396 DLK A POTENTIAL NEW IMMUNOHISTOCHEMICAL MARKER FOR HEPATOBLASTOMADezso, K. / Halasz, J. / Paku, S. / Bisgaard, H. C. / Schaff, Z. / Nagy, P. et al. | 2008
- S154
-
399 BONE MARROW STEM CELLS EXPRESSING CD34 ARE MOBILIZED IN DIFFERENT HISTOTYPES OF LIVER CANCERNovi, M. / Rinninella, E. / Piscaglia, A. C. / Lauritano, E. C. / Zocco, M. A. / Saulnier, N. / Puglisi, M. A. / Giuliante, F. / Barbaro, F. / Serricchio, M. L. et al. | 2008
- S155
-
402 INCIDENCE OF LATE (<2 YEARS) HCC RECURRENCE AFTER SURGICAL RESECTION REMAINS HIGHER THAN OF FIRST HCC IN CIRRHOSIS: IMPLICATIONS FOR PATIENTS MANAGEMENTPiscaglia, F. / Cucchetti, A. / Benvegnu, L. / Caturelli, E. / Gianstefani, A. / Ercolani, G. / Vivarelli, M. / Grazi, G. L. / Bolondi, L. / Pinna, A. D. et al. | 2008
- S156
-
405 THE CLINICAL CHARACTERISTICS OF ACUTE KIDNEY INJURY AFTER TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMAShin, J. W. / Park, J. / Kim, D. M. / Hwang, J. C. / Cho, M. W. / Chung, H. C. / Lee, J. S. / Park, N. H. et al. | 2008
- S157
-
408 HIGH METABOLISM THROMBUS OF THE PORTAL VEIN: 18F FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTER TOMOGRAPHY DEMONSRATION AND CLINICAL SIGNIFICANCE IN HEPATOCELLULAR CARCINOMASun, L. et al. | 2008
- S160
-
416 RESULTS OF 6 YEARS EXPERIENCE OF LIVER SECONDARIES TREATED BY RADIOFREQUENCY ABLATIONSingh, V. / Mishra, P. / Sharma, S. / Naik, S. / Purohit, D. / Sewkani, A. / Maudar, K. K. / Varshney, S. et al. | 2008
- S161
-
419 PERCUTANEOUS RADIOFREQUENCY ABLATION IN THE TREATMENT OF INTERMEDIATE HEPATOMA WITH LEVEEN ELECTORDES-A COMPARISON WITH SMALL HEPATOMAYen, C. L. / Huang, J. S. / Chen, L. W. / Chang, J. J. / Lai, C. H. / Chang, L. C. et al. | 2008
- S162
-
422 URSODEOXYCHOLIC ACID MODULATES THE UBIQUITIN-PROTEASOME DEGRADATION PATHWAY OF P53Amaral, J. D. / Castro, R. E. / Sola, S. / Rodrigues, C. M. et al. | 2008
- S163
-
425 PROTECTIVE ACTIVITY OF RESVERATROL ON TERT-BUTYLHYDRPEROXIDE AND D-GALACTOSAMINE INDUCED HEPTOCYTE APOPTOSIS AND NECROSIS IN VITRO AND IN VIVOFarghali, H. / Cerny, D. / Kutinova Canovaa, N. / Martinek, J. et al. | 2008
- S164
-
428 MICRORNAS FUNCTION IN ENDODERMAL DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLSTzur, G. / Meiri, E. / Barad, O. / Levi, A. / Bentwich, Z. / Reubinoff, B. E. / Galun, E. et al. | 2008
- S165
-
432 EFFECTS OF CADMIUM AND ALPHA-LIPOIC ACID ON THE ANTIOXIDANT, STRESS AND APOPTOTIC RESPONSE OF HEPG2 CELLSMacias-Barragan, J. G. / Huerta-Olvera, S. H. / Siller-Lopez, F. et al. | 2008
- S166
-
435 SENSITIZATION OF HEPATOCELLULAR CARCINOMA CELLS TO RETINOIC ACID-INDUCED APOPTOSISMyung, S. J. / Lee, J. H. / Kim, B. H. / Yoon, J. H. / Jung, G. E. / Lee, H. S. / Lee, J. S. / Lee, Y. J. et al. | 2008
- S167
-
438 THE EXPRESSION OF P27 REDUCES DNA MUTAGENESIS AND CELL DEATH IN AFLATOXIN B1 INDUCED GENOTOXICITY IN HEPATOCYTES. IMPACT OF P27 AND P21 IN HUMAN HEPATOCARCINOGENESISRanchal, I. / Poyato, A. / Barrera, P. / Pleguezuelo, M. / Marchal, T. / Nakayama, K. I. / De la Mata, M. / Muntane, J. et al. | 2008
- S168
-
441 SURVIVIN-TARGETED RNA INTERFERENCE INDUCES CELL CYCLE REDISTRIBUTION AND APOPTOTIC GROWTH INHIBITION OF HEPATOMA CELLSSong, I. H. / Kim, E. Y. / Kim, D. W. / Shin, K. C. / Yun, S. Y. / Kim, S. B. / Shin, J. E. / Kim, H. J. / Yang, S. H. et al. | 2008
- S170
-
447 SKP2 OVEREXPRESSION AND CYTOPLASMIC P27KIP1 IMMUNOREACTIVITY ARE PREDICTORS OF POOR PROGNOSIS IN PATIENTS WITH EXTRAHEPATIC BILE DUCT CANCERBaek, Y. H. / Kim, H. J. / Park, J. H. / Park, D. I. / Cho, Y. K. / Sohn, C. I. / Jeon, W. K. / Kim, B. I. / Kim, M. K. / Kim, D. H. et al. | 2008
- S171
-
450 HEPATOCYTES AND CHOLANGIOCYTES EXPRESS THE LOCALLY ACTING IGF1 ISOFORM WHICH IS INVOLVED IN CELL PROLIFERATION AND RESISTANCE AGAINST CHOLESTATIC INJURYGatto, M. / Torrice, A. / Mancino, M. G. / Cantafora, A. / Alvaro, D. et al. | 2008
- S172
-
453 THE EFFECT OF HMG-COA REDUCTASE INHIBITORS (STATINS) ON PPAR AND ABCA1 EXPRESSION IN CULTURED GALLBLADDER EPITHELIAL CELLSLee, J. / Hong, E. M. / Koh, D. H. / Park, S. H. / Choi, M. H. / Jang, H. J. / Kae, S. H. et al. | 2008
- S173
-
456 OSTEOPONTIN, A PUTATIVE MARKER FOR DUCTULAR REACTION, IS INDUCED BY JAK/STAT3 ACTIVATION IN HUMAN BILIARY EPITHELIAL CELLSKomori, A. / Uemura, T. / Fujiwara, S. / Aiba, Y. / Nakamura, M. / Fujioka, H. / Yano, K. / Migita, K. / Yatsuhashi, H. / Ishibashi, H. et al. | 2008
- S175
-
461 THE ENDOCANNABINOID SYSTEM IS UP-REGULATED IN PRIMARY BILIARY CIRRHOSISLazzari, R. / Variola, A. / Candeo, N. / Macchi, V. / Guido, M. / Colavito, D. / Leon, A. / Bergasa, N. V. / Floreani, A. et al. | 2008
- S176
-
464 ATTENUATION OF HEPATIC INFLAMMATION BY ADMINISTRATING CD55 TO A MURINE MODEL OF STEATOHEPATITISChang, M. L. / Yeh, C. T. / Chiu, C. T. / Lin, D. Y. / Liaw, Y. F. et al. | 2008
- S179
-
472 THE TRIPLEHELICAL PEPTIDE (GPO)10 INTERACTS WITH THE CBD OF MMP-2 RESULTING IN A DIMINISHED BINDING OF MMP-2 TO FIBRILLAR LIVER COLLAGENS AND ENHANCED MATRIX DEGRADATIONFreise, C. H. / Ruehl, M. / Erben, U. / Seja, M. / Farndale, R. / Zeitz, M. / Somasundaram, R. et al. | 2008
- S180
-
475 THE EFFECT OF S-ALLYL CYSTEINE ON CCL4-INDUCED LIVER FIBROSIS AND ON PRIMARY HEPATIC STELLATE CELLSKodai, S. / Takemura, S. / Minamiyama, Y. / Hai, S. / Yamamoto, S. / Mizuguchi, S. / Shinkawa, H. / Kubo, S. / Okada, S. / Suehiro, S. et al. | 2008
- S182
-
480 GAS6 IS CONSTITUTIVELY PRODUCED BY HUMAN STELLATE CELLS AND ITS PLASMA CONCENTRATION REFLECTS CIRRHOSIS PROGRESSIONMarconi, C. / Minisini, R. / Sainaghi, P. / Franzosi, L. / Alciato, F. / Fabris, C. / Toniutto, P. / Avanzi, G. / Pirisi, M. et al. | 2008
- S183
-
483 EFFECT OF PIRFENIDONE IN TH1/TH2 RESPONSE IN EXPERIMENTAL LIVER FIBROSISNavarro-Partida, J. / Marquez-Aguirre, A. L. / Martinez-Rizo, A. B. / Galvez-Gastelum, J. / Gonzalez-Cuevas, J. / Armendariz-Borunda, J. et al. | 2008
- S184
-
486 IDENTIFICATION OF A NOVEL MOLECULAR CANDIDATE-GLIA MATURATION FACTOR-BETA FOR ACTIVATION OF HEPATIC STELLATE CELLSRao, H. Y. / Wang, J. H. / Liu, F. / Fei, R. / Liu, Z. D. / Wei, L. et al. | 2008
- S185
-
489 HEPATIC FIBROGENESIS IN ABCB4 KNOCK OUT MOUSE MODEL FOR BILIARY FIBROSIS IS MEDIATED BY HEPATIC STELLATE CELLSRoderfeld, M. / Atanasova, S. / Rath, T. / Tschuschner, A. / Roeb, E. et al. | 2008
- S186
-
492 CCL5 AND CCR5 EXPRESSION AS A SURROGATE MARKER FOR THE STAGE OF FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS CWang, B. / Katsounas, A. / Trippler, M. / Gerken, G. / Schlaak, J. F. et al. | 2008
- S187
-
495 INTERFERON-BETA (IFN) INCREASES METALLOPROTEINASE-13 (MMP-13) GENE EXPRESSION THROUGH A JAK1/PEA3-DEPENDENT PATHWAYDiaz-Sanjuan, T. / Garcia-Ruiz, I. / Rodriguez-Juan, C. / Fernandez-Vazquez, I. / Solis-Munoz, P. / Solis-Herruzo, J. A. et al. | 2008
- S188
-
498 ETHANOL-INDUCED LIVER FIBROSIS IS REDUCED IN CB1-K.O. AND ENHANCED IN CB2-K.O. MICETrebicka, J. / Racz, I. / Cara, E. / Hennenberg, M. / Zimmer, A. / Sauerbruch, T. / Heller, J. et al. | 2008
- S189
-
501 18-BETA-GLYCYRRHETIC ACID, METABOLITE OF GLYCYRRHIZIN, INDUCES APOPTOSIS AND SUPPRESS THE EXPRESSION OF COLLAGEN TYPE I GENE IN HEPATIC STELLATE CELLSYanagida, A. / Hatano, E. / Uyama, N. / Narita, M. / Asechi, H. / Nagata, H. / Ikeda, K. / Kawada, N. / Ikai, I. / Uemoto, S. et al. | 2008
- S190
-
504 THE EFFECT OF FAK-RELATED NON-KINASE PLASMID TRANSFECTION ON FIBRONECTIN-STIMULATED HEPATIC STELLATE CELLS BEHAVIOURSZhang, X. L. / An, J. Y. / Shen, J. G. / Huo, X. X. / Wei, J. et al. | 2008
- S191
-
507 ROLE OF MIR-21 IN REGENERATING RAT LIVERCastro, R. E. / Santos, D. M. / Zeng, Y. / Steer, C. J. / Rodrigues, C. M. / Kren, B. T. et al. | 2008
- S193
-
512 IN VITRO PRODUCTION OF HEPATOCYTES FROM HUMAN EMBRYONIC STEM CELLSFunakoshi, N. / Gerbal-Chaloin, S. / Daujat-Chavanieu, M. / Navarro, F. / Maurel, P. / Blanc, P. et al. | 2008
- S194
-
515 INSULIN PRODUCTION AND PANCREATIC GENE EXPRESSION ANALYSIS IN HUMAN FETAL LIVER PROGENITOR CELLSHabibullah, C. M. / Khan, A. A. / Parveen, N. / Vali, S. M. / Rajendraprasad, A. / Habeeb, M. A. et al. | 2008
- S195
-
519 ISOLATION OF HEPATIC STEM CELLS USING A NOVEL SURFACE ANTIGEN;GP38Konoshi, S. / Yasuchika, K. / Ishii, T. / Machimoto, T. / Kamo, N. / Shimoda, M. / Komori, J. / Babazono, Y. / Fukumitsu, K. / Ikai, I. et al. | 2008
- S196
-
522 THE ROLE OF ENDOTHELIAL PROGENITOR CELLS TRANSPLANTED IN RATS WITH HEPATIC CIRRHOSISLiu, F. / Liu, Z. D. / Wu, N. / Cong, X. / Fei, R. / Wei, L. et al. | 2008
- S197
-
525 EFFECT OF 5-HT7 RECEPTOR BLOCKADE ON LIVER REGENERATION AFTER PARTIAL HEPATECTOMYTzirogiannis, K. N. / Papadimas, G. K. / Demonakou, M. D. / Skaltsas, S. D. / Grypioti, A. D. / Kourentzi, K. T. / Alexandropoulou, K. N. / Tairis, N. / Mykoniatis, M. G. / Panoutsopoulos, G. I. et al. | 2008
- S198
-
528 IN VITRO EVALUATION OF HEPATIC TRANSDIFFERENTIATION OF ADIPOSE- AND BONE MARROW-DERIVED STROMAL CELLSSaulnier, N. / Puglisi, M. A. / Barba, M. / Piscaglia, A. C. / Novi, M. / Lauritano, E. C. / Alfieri, S. / Leone, G. / Gasbarrini, G. / Gasbarrini, A. et al. | 2008
- S199
-
531 THE ROLE OF PLACENTAL GROWTH FACTOR AND ITS RECEPTOR IN LIVER REGENERATION AFTER PARTIAL HEPATECTOMYVanheule, E. / Fan, Y. D. / Huysse, J. V. / Meester, D. / Praet, M. / de Hemptinne, B. / Colle, I. et al. | 2008
- S200
-
534 ADIPOCYTES MESENCHYMAL STEM CELLS EXPRESS LIVER SPECIFIC GENES SUGGESTING HEPATIC PREDISPOSITION AND TRANSDIFFERENTIATIONZemel, R. / Bachmatov, L. / Ad-El, D. / Tur-Kaspa, R. et al. | 2008
- S201
-
537 LOW VOLUME HYDRODYNAMIC GENE DELIVERY TO RAT LIVER VIA AN ISOLATED SEGMENT OF THE INFERIOR VENA CAVA: EFFICIENCY, CARDIOVASCULAR RESPONSE AND INTRAHEPATIC VASCULAR DYNAMICSSawyer, G. J. / Grehan, A. / Dong, X. / Whitehorne, M. / Seddon, M. / Shah, A. M. / Zhang, X. / Salehi, S. / Fabre, J. W. et al. | 2008
- S203
-
542 INTERNAL RADIOTHERAPY OF LIVER CANCER USING RAT HEPATOCARCINOMA-INTESTINE-PANCREAS GENE AS A LIVER TUMOR-SPECIFIC PROMOTERHerve, J. / Sa Cunha, A. / Liu, B. / Valogne, Y. / Longuet, M. / Bregerie, O. / Boisgard, R. / Roux, J. / Guettier, C. / Cales, P. et al. | 2008
- S206
-
551 THE FOUNDER EFFECT DRIVES THE ADAPTATION OF HUMAN HEPATITIS DELTA VIRUS IN WOODCHUCK MODELArgentini, C. / Canitano, A. / DUgo, E. / Orobello, S. / Catone, S. / Giuseppetti, R. / Rapicetta, M. et al. | 2008
- S207
-
553 THE EXPRESSION OF SOCS-1 IN THE LIVER OF CHRONIC HEPATITIS B AND ITS SIGNIFICANCECai, Q. X. / Zhao, Z. X. / Peng, X. M. / Chong, Y. T. / Gao, Z. L. et al. | 2008
- S208
-
556 ROLE OF IL-10-PRODUCING REGULATORY B CELLS IN THE PATHOGENESIS OF CHRONIC HBV INFECTIONDas, A. / Ellis, G. / Peppa, D. / Brunetta, M. / Blair, P. / Mauri, C. / Maini, M. K. et al. | 2008
- S210
-
561 RECONSTITUTION OF HBV SPECIFIC IMMUNITY VIA RETROVIRAL GENE TRANSFER OF A HBV CORE SPECIFIC T CELL RECEPTOR IN CHRONIC HEPATITIS B PATIENTSGehring, A. J. / Xue, S. A. / Lim, S. G. / Maini, M. K. / Stauss, H. / Bertoletti, A. et al. | 2008
- S211
-
564 IMPACT OF ANTIVIRAL THERAPY ON GLOBAL CD8 T CELL DEFECTS IN CHRONIC HBV INFECTIONLee, C. K. / Khanna, P. / Das, A. / Matull, R. / Han, K. J. / Dusheiko, G. M. / Maini, M. K. et al. | 2008
- S215
-
576 SIMULTANEOUS DETERMINATION OF TENOFOVIR, ADEFOVIR, LAMIVUDINE, ENTECAVIR IN PLASMADelepee, R. / Got, L. / Causse, X. / Agrofoglio, L. A. / Si Ahmed, S. N. et al. | 2008
- S216
-
578 CONSTRUCTION OF THE RECOMBINANT ADENOVIRUS WITH A HIGHLY REPLICATIVE HBV GENOMEYin, H. / Tang, H. / Zhou, T. Y. / Li, H. / Wang, Y. B. / Han, H. X. et al. | 2008
- S217
-
581 HBV SUPPRESSES TLR-MEDIATED INNATE IMMUNE RESPONSES IN MURINE PARENCHYMAL AND NON-PARENCHYMAL LIVER CELLSWu, J. / Meng, Z. / Trippler, M. / Broering, R. / Szczeponek, A. / Sowa, J. P. / Castro, E. M. / Driftmann, S. / Dittmer, U. / Yang, D. et al. | 2008
- S218
-
584 TOLL LIKE RECEPTOR MEDIATED SUPPRESSION OF WOODCHUCK HEPATITIS VIRUS REPLICATION IN PRIMARY WOODCHUCK HEPATOCYTESZhang, X. Y. / Meng, Z. J. / Qiu, S. / Xu, Y. / Wu, J. / Schlaak, J. / Roggendorf, M. / Lu, M. J. et al. | 2008
- S219
-
587 A NEW CLASS OF POTENT INHIBITORS OF HCVRNADEPENDANT RNA POLYMERASEAhmed-Belkacem, A. / Brillet, R. / Pallier, C. / Pawlotsky, J. M. et al. | 2008
- S220
-
590 HEPATITIS C VIRUS (HCV) CORE PROTEIN TRIGGERS HEPATIC ANGIOGENESIS BY A MECHANISM INCLUDING MULTIPLE PATHWAYSSelimoivic, D. / Ghozlan, H. / Haikel, Y. / Hassan, M. et al. | 2008
- S221
-
593 SMOKING AND HEPATITIS C: INFLUENCE ON FIBROSIS PROGRESSION AND SUSTAINED RESPONSEMadrazo, A. / Grande, L. / Lara, L. / Jover, M. / Pardo, B. / Romero-Gomez, M. et al. | 2008
- S222
-
596 TETRASPANIN-ENRICHED MICRODOMAINS INVOLVEMENT IN HEPATITIS C VIRUS INFECTION: ROLE OF CD151Sanz-Cameno, P. / Martin-Vilchez, S. / Borque, M. J. / Rodriguez-Munoz, Y. / Majano, P. L. / Garcia-Buey, L. / Trapero-Marugan, M. / Lopez-Cabrera, M. / Moreno-Otero, R. et al. | 2008
- S223
-
599 PEG-IFN ALFA 2A INDUCED IMMIDIATE CYTOKINE RELEASE IN PATIENTS WITH CRONIC HCV INFECTIONAntonov, K. / Jelev, D. / Kolchakov, V. / Krastev, Z. et al. | 2008
- S224
-
602 ASSOCIATION BETWEEN HCV INFECTION CONTROL AND DEVELOPMENT OF A SPECIFIC CYTOTOXIC CELLULAR RESERVOIR PD1 NEGATIVEBenito, S. / Larrubia, J. R. / Sanz-de-Villalobos, E. / Calvino, M. / Garcia-Buey, M. L. / Gonzalez-Mateos, F. / Gonzalez-Praetorius, A. / Miquel, J. / Bienvenido, A. / Parra, T. et al. | 2008
- S225
-
605 TREG CELLS CD4+CD25+ IN CHRONIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA EGYPTIAN PATIENTSEl Bassuoni, M. A. / Obada, M. A. / Korah, T. A. / El Sayed, S. A. et al. | 2008
- S227
-
610 IL-22, SFAS AND SFASL CONCENTRATION IN SERA OF HCV 1B GENOTYPE-INFECTED PATIENTS TREATED WITH PEGYLATED INTERFERON ALPHA 2B AND RIBAVIRINLapinski, T. W. / Dabrowska, M. M. / Jaroszewicz, J. / Flisiak, R. et al. | 2008
- S228
-
613 EFFECT OF CHRONIC HCV INFECTION ON HELPER T CELL SKEWING CAPACITY OF CIRCULATING PLASMACYTOID DENDRITIC CELLS. THE INFLUENCE OF ANTIVIRAL TREATMENT (RIBAVIRIN)Pachiadakis, I. / Chokshi, S. / Cooksley, H. / Farmakiotis, D. / Naoumov, N. V. et al. | 2008
- S229
-
616 DIFFERENT IMMUNE CELL CYTOKINE EXPRESSION PROFILES CHARACTERIZE CHRONIC HEPATITIS C AND OCCULT HEPATITIS C VIRUS INFECTIONPham, T. N. / Mercer, S. E. / Michalak, T. I. et al. | 2008
- S230
-
619 INTRAHEPATIC ANGIOPOIETIN-2 PROTEIN EXPRESSION MODULATION BY HEPATITIS C VIRUS: MAPK, PI3K AND REACTIVE OXYGEN SPECIES (ROS) IMPLICATIONSanz-Cameno, P. / Martin-Vilchez, S. / Rodriguez-Munoz, Y. / Borque, M. J. / Majano, P. L. / Molina-Jimenez, F. / Lopez-Cabrera, M. / Moreno-Otero, R. et al. | 2008
- S231
-
622 COMPREHENSIVE ASSESSMENT OF HCV CD4+ EPITOPES THROUGH CONVENTIONAL MAPPING COMBINED WITH COMPUTATIONAL ANALYSISSchulzezur Wiesch, J. / Listgarden, J. / Li, B. / Nawar, H. / Kasprowicz, V. / Nolan, B. / Blum, J. / Lewis-Ximenez, L. / McGovern, B. / Kuntzen, T. et al. | 2008
- S232
-
625 POLYMORPHISMS IN TOLL-LIKE RECEPTORS 1 AND 2 ARE NOT ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS CNischalke, H. D. / Reich, B. / Aldenhoff, K. / Nattermann, J. / Sauerbruch, T. / Spengler, U. et al. | 2008
- S234
-
630 SERUM BLYS/BAFF LEVELS IN ACUTE HEPATITIS C PREDICT CLINICAL OUTCOMETarantino, G. / Di Marco, V. / Almasio, P. L. / Barbaria, F. / Ciaccio, A. / DAntoni, F. / Di Stefano, R. / Iaco, A. / Licata, A. / Petta, S. et al. | 2008
- S236
-
635 A SELF-ADJUVANTING LIPOPEPTIDE VACCINE FOR IMMUNOTHERAPY OF HEPATITIS C VIRUS INFECTION ACTIVATES DENDRITIC CELLS AND INDUCES ANTIGEN-SPECIFIC T CELL RESPONSESChua, B. Y. / Brown, L. E. / Zeng, W. / Torresi, J. / Jackson, D. C. et al. | 2008
- S237
-
638 PARVOVIRUS B19 INFECTION: EVIDENCE FOR INTRAHEPATIC LONG-TERM PERSISTENCE BUT NO ASSOCIATION WITH DISEASE PROGRESSION IN CHRONIC HEPATITIS CWang, C. / Heim, A. / Schlaphoff, V. / Suneetha, P. V. / Jiang, H. / Krueger, M. / Fytili, P. / Stegmann, K. / Bock, T. / Manns, M. P. et al. | 2008
- S239
-
643 A PROSPECTIVE STUDY OF THE DIAGNOSTIC ACCURACY OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE EVALUATION OF HEPATIC FIBROSIS IN ASIANS COMPARED WITH LIVER BIOPSY AND APRIChang, P. E. / Lui, H. F. / Chau, Y. P. / Lim, K. H. / Yap, W. M. / Tan, C. K. / Chow, W. C. et al. | 2008
- S241
-
648 CHANGING PATTERN OF HEPATITIS DELTA VIURS INFECTION IN THE NORTHEAST OF SPAIN (CATALONIA) DURING THE LAST 25 YEARSFunalleras, G. / Homs, M. / Buti, M. / Schaper, M. / Rodriguez-Frias, F. / Jardi, R. / Esteban, R. et al. | 2008
- S242
-
651 VIROLOGICAL AND CLINICAL PATTERNS OF DELTA HEPATITIS IN CENTRAL EUROPE: A SINGLE CENTER EXPERIENCE WITH 255 PATIENTSHeidrich, B. / Tillmann, H. L. / Deterding, K. / Cornberg, M. / Manns, M. P. / Wedemeyer, H. et al. | 2008
- S246
-
661 DIAGNOSTIC PERFORMANCE OF NON-INVASIVE SCORES FOR THE DIAGNOSIS OF LIVER FIBROSIS IN CHRONIC HEPATITIS BLeroy, V. / Sturm, N. / Trocme, C. / Hilleret, M. N. / Faure, P. / Renversez, J. C. / Morel, F. / Zarski, J. P. et al. | 2008
- S247
-
664 AN ACCURATE DEFINITION OF THE STATUS OF INACTIVE HBSAG CARRIER (IC) BY A COMBINATION OF BIOMARKERS AND VIRAL LOAD (VL)Ngo, Y. / Benhamou, Y. / Thibault, V. / Ingiliz, P. / Munteanu, M. / Lebray, P. / Thabut, D. / Morra, R. / Messous, D. / Imbert-Bismut, F. et al. | 2008
- S248
-
667 HEPATITIS B VIRUS DNA LEVEL IS A SIGNIFICANT PREDICTIVE FACTOR FOR HEPATITIS B VIRUS REACTIVATION IN INACTIVE HBS ANTIGEN CARRIERSSeo, Y. S. / Kwon, Y. D. / Park, S. / Keum, B. / Kim, Y. S. / Yim, H. J. / Jeen, Y. T. / Chun, H. J. / Kim, C. D. / Ryu, H. S. et al. | 2008
- S251
-
676 EFFECT OF INFLAMMATORY ACTIVITY ON THE LIVER STIFFNESS MEASUREMENT IN CHRONIC HEPATITIS B PATIENTSYoon, K. T. / Kim, J. K. / Park, J. Y. / Kim, D. Y. / Ahn, S. H. / Baatarkhuu, O. / Moon, B. S. / Chon, C. Y. / Moon, Y. M. / Han, K. H. et al. | 2008
- S252
-
679 MULTIVARIATE PROGNOSTIC ANALYSIS OF CHRONIC LIVER FAILUREZhao, Z. X. / Xie, D. Y. / Chong, Y. T. / Gao, Z. L. / Yao, J. L. et al. | 2008
- S255
-
686 STRONG DECREASE OF ANTI-HEPATITIS B SURFACE ANTIGEN ANTIBODIES FOLLOWING RENAL TRANSPLANTATIONMoal, V. / Motte, A. / Vacher-Coponat, H. / Gerolami, R. / Tamalet, C. / Berland, Y. / Colson2, P. et al. | 2008
- S256
-
689 LACK OF INFLUENCE OF BASELINE GENOTYPE ON ANTIVIRAL RESPONSE IN SUBJECTS WITH CHRONIC HEPATITIS B INFECTION RECEIVING TENOFOVIR DF 300 MG QD FOR 1 YEARGane, E. / Benhamou, Y. / Gladysz, A. / Zeuzem, S. / Germanidis, G. / Heathcote, J. / Marcellin, P. / Sorbel, J. / Borroto-Esoda, K. / Rousseau, F. et al. | 2008
- S260
-
699 COMBINATION THERAPY WITH NUCLEOS(T)IDE ANALOG REVERSE TRANSCRIPTASE INHIBITORS (NRTI): USING IN VITRO PHENOTYPING TO OPTIMISE NRTI COMBINATIONS FOR TREATMENT OF MULTIDRUG-RESISTANT HBVShaw, T. / Sozzi, T. / Locarnini, S. A. et al. | 2008
- S263
-
706 SUSTAINED DURABILITY OF HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B PATIENTS AFTER TREATMENT WITH TELBIVUDINEPoynard, T. / Hou, J. L. / Chutaputti, A. / Manns, M. / Naoumov, N. et al. | 2008
- S264
-
709 LONG-TERM TREATMENT WITH LAMIVUDINE UP TO TEN YEARS: PREDICTIVE VALUE OF HOST AND VIRUS RELATED RISK FACTORS FOR THE DEVELOPMENT OF HBV RESISTANCEvan Bommel, F. / Brodzinski, A. / Mihm, U. / Jung, M. C. / Sarrazin, C. / Bergk, A. / Schlosser, B. / Weich, V. / Muller, T. / Schott, E. et al. | 2008
- S266
-
714 THREE-YEARS OF CONTINUOUS TREATMENT WITH ENTECAVIR RESULTS IN HIGH PROPORTIONS OF CHINESE NUCLEOSIDE-NAIVE PATIENTS WITH UNDETECTABLE HBVDNA: RESULTS FROM STUDIES ETV-023 AND -050Yao, G. B. / Xu, D. Z. / Ren, H. / Zhou, X. Q. / Jia, J. D. / Wang, Y. M. / Chen, C. W. / Liu, J. / Xu, D. / Llamoso, C. et al. | 2008
- S267
-
716 DISCOVERY OF THE MISSED LINK BETWEEN SCHISTOSOMIASIS AND HCV INFECTIONSoliman, A. A. / Zaki, S. A. / Abd El Moety, A. A. / Abd El Moety, H. A. et al. | 2008
- S268
-
719 HCV-SPECIFIC CELLULAR IMMUNE RESPONSES (SCIR) IN HETEROSEXUAL PARTNERS OF PATIENTS WITH CHRONIC HEPATITIS CAguilar-Reina, J. / Roque-Cuellar, M. C. / Alvarez-Marquez, M. A. / Garcia-Lozano, R. / Nunez, A. / Gonzalez-Escribano, M. F. / Sanchez, B. et al. | 2008
- S270
-
724 OUTBREAK OF A NEW HEPATITIS C VIRUS SUBTYPE (SUBTYPE 1M) IN A HEMODIALYSIS UNIT: HOW NEW HCV GENOTYPES START THEIR SPREADChevaliez, S. / Brillet, R. / Sehonou, J. / Barbotte, L. / Pawlotsky, J. M. et al. | 2008
- S271
-
727 PREDICTIVE FACTORS FOR THE EVOLUTION OF PATIENTS WITH HCV LIVER CIRRHOSIS TO HEPATOCELLULAR CARCINOMACopaci, I. / Micu, L. / Voiculescu, M. et al. | 2008
- S272
-
730 LACK OF ASSOCIATION BETWEEN MATRIX METALLOPROTEINASE (MMP)-1, MMP-3 AND MMP-9 PROMOTER POLYMORPHISMS AND LIVER FIBROSIS IN CHRONIC HEPATITIS CEisele, S. / Oesterreicher, C. H. / Patsenker, E. / Schneider, V. / Stickel, F. et al. | 2008
- S274
-
735 DYNAMIC HUE HISTOGRAM AND NEURAL NETWORKS ANALYSIS OF REAL-TIME ELASTOGRAPHY FOR NON-INVASIVE ASSESSMENT OF LIVER FIBROSISSaftoiu, A. / Gheonea, D. I. / Ciurea, T. et al. | 2008
- S275
-
738 BONE MINERAL DENSITY AND METABOLISM IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS CHofmann, W. P. / Kronenberger, B. / Bojunga, J. / Stamm, B. / Herrmann, E. / Buecker, A. / Mihm, U. / von Wagner, M. / Zeuzem, S. / Sarrazin, C. et al. | 2008
- S276
-
741 IMPAIRED TRANSCRIPTIONAL REGULATION OF TRANSFERRIN RECEPTOR 2 AND ITS ROLE IN INSUFFICIENT HEPCIDIN EXPRESSION IN HCV-TRANSFECTED CELLSKobayashi, Y. / Konishi, M. / Sugimoto, R. / Fujita, N. / Takei, Y. et al. | 2008
- S277
-
744 INSULIN RESISTANCE AND STEATOSIS ARE RELATED TO LOW ADIPONECTIN LEVELS IN NO-DIABETIC PATIENTS WITH HCV GENOTYPE NO-3 CHRONIC HEPATITISLo Iacono, O. / Nunez, O. / Lozano, M. / Matilla, A. / Rincon, D. / Gomez, J. / Hernando, A. / Clemente, G. / Banares, R. et al. | 2008
- S279
-
749 INDEPENDENT OF INSULIN RESISTANCE AND OTHER ADIPOCYTOKINES, TNF ALPHA IS AN INDEPENDENT PREDICTOR OF FIBROSIS AND NECROINFLAMMATION IN CHRONIC HEPATITIS CNachnani, J. S. / Mathur, S. / Callahan, P. J. / Reker, D. / Pandya, P. K. et al. | 2008
- S280
-
752 DETECTION OF ANTIBODIES TO HCV CORE IN PATIENTS WITH SEROLOGICALLY SILENT OCCULT HCV INFECTIONQuiroga, J. A. / Castillo, I. / Llorente, S. / Bartolome, J. / Carreno, V. et al. | 2008
- S281
-
755 YKL-40 AND HYALURONIC ACID (HA) AS NONINVASIVE MARKERS OF LIVER FIBROSIS IN KIDNEY TRANSPLANT PATIENTS WITH HCV CHRONIC INFECTIONSchiavon, L. L. / Narciso-Schiavon, J. L. / Carvalho-Filho, R. J. / Lanzoni, V. P. / Silva, A. E. / Ferraz, M. L. et al. | 2008
- S282
-
757 HISTOPATHOLOGICAL FINDING RELATED TO AGE AT INFECTION IN CHILDREN WITH CHRONIC HEPATITIS CMania, A. / Sluzewski, W. / Mozer-Lisewska, I. / Figlerowicz, M. / Kowala-Piaskowska, A. / Bujnowska, A. / Kemnitz, P. et al. | 2008
- S284
-
762 TRANSIENT ELASTOGRAPHY (TE) IS MORE EFFECTIVE FOR THE IDENTIFICATION OF HCV PATIENTS WITH ADVANCED (F3-F4) RATHER THAN SIGNIFICANT (F2-F4) LIVER FIBROSISArena, U. / Vizzutti, F. / Abraldes, J. G. / Corti, G. / Stasi, C. / Moscarella, S. / Milani, S. / Lorefice, E. / Petrarca, A. / Laffi, G. et al. | 2008
- S285
-
765 GENE EXPRESSION ASSOCIATED WITH ADCANCED FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C)Younossi, Z. M. / Baranova, A. / Stepanova, M. / Schmidt, S. / Younossi, I. / Nader, F. / Santini, C. / Chan, J. / Chang, S. Y. et al. | 2008
- S289
-
776 PATIENT EDUCATION IMPROVES ADHERENCE TO PEGINTERFERON AND RIBAVIRIN IN CHRONIC GENOTYPE 2 OR 3 HEPATITIS C VIRUS (HCV) INFECTION IN THE REAL-LIFECacoub, P. / Melin, P. / Ouzan, D. / Cattan, L. / Chousterman, M. / Varastet, M. / Rotily, M. / Fontanges, T. / Lang, J. P. / Marcellin, P. et al. | 2008
- S290
-
779 BASELINE FACTORS ASSOCIATED WITH RAPID AND EARLY VIROLOGICAL RESPONSES IN HCV GENOTYPE 1 PATIENTS TREATED WITH INDUCTION DOSING OF PEGYLATED INTERFERON: THE CHARIOT STUDYCrawford, D. H. / Roberts, S. / Weltman, M. / Cheng, W. S. / Sievert, W. / McCaughan, G. / Desmond, P. / Alston, A. W. / DePamphilis, J. / Marks, P. et al. | 2008
- S292
-
784 IRF-1 GENE EXPRESSION CHANGES IN HCV PATIENTS WITH PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPHYDominguez-Lopez, A. / Sixtos-Alonso, M. S. / Bueno-Hernandez, N. / Sanchez-Munoz, F. / Sanchez-Avila, J. F. / Uribe-Esquivel, M. et al. | 2008
- S294
-
789 THE IMPACT OF A MULTI-DISCIPLINARY SUPPORT PROGRAM ON ADHERENCE AND THE EFFICACY OF HEPATITIS C TREATMENTGarcia-Retortillo, M. / Cirera, I. / Gimenez, M. D. / Marquez, C. / Galeras, J. A. / Castellvi, P. / Navines, R. / Salas, E. / Bory, F. / Martin-Santos, R. et al. | 2008
- S295
-
792 CLINICAL AND PERSISTENCY OUTCOMES IN HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B PLUS RIBAVIRINHassanein, T. I. / Ye, X. / Blumentals, W. A. / Brixner, D. I. et al. | 2008
- S297
-
797 EASY TO ASSESS ON-TREATMENT PARAMETERS CORRELATE WITH DEGREE OF VIROLOGICAL RESPONSE AFTER 12 WEEKS OF TREATMENTJensen, D. / Freilich, B. / Andreone, P. / DiBisceglie, A. / Brandao, C. E. / Reddy, K. R. / Craxi, A. / Olveira, A. / Teuber, G. / Messinger, D. et al. | 2008
- S298
-
800 SUSTAINED VIROLOGIC RESPONSE TO INTERFERON ALFA-2B PLUS RIBAVIRIN PREDICTS LONG-TERM CLEARANCE OF HCV IN PEDIATRIC PATIENTS AT 5 YEAR FOLLOW-UPKelly, D. / Haber, B. / Gonzalez-Peralta, R. P. / Murray, K. F. / Jonas, M. M. / Molleston, J. P. / Narkewicz, M. R. / Sinatra, F. R. / Lang, T. / Lachaux, A. et al. | 2008
- S302
-
809 SUSTAINED VIROLOGICAL RESPONSE IS ASSOCIATED WITH ERADICATION OF HEPATITIS C VIRUS AND DECREASE IN ANTI-HCV TITER IN PATIENTS TREATED FOR CHRONIC HEPATITIS CMartinot-Peignoux, M. / Maylin, S. / Boyer, N. / Cardoso, A. C. / Ripault, M. P. / Giuily, N. / Castelnau, C. / Pouteau, M. / Bedossa, P. / Marcellin, P. et al. | 2008
- S303
-
811 ESTIMATING THE LIKELIHOOD OF SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C (CHC) THERAPYMauss, S. / Hueppe, D. / John, C. / Goelz, J. / Meyer, U. / Heyne, R. / Moeller, B. / Link, R. / Teuber, G. / Sworszt, S. et al. | 2008
- S305
-
816 THE TGF-b HIGH PRODUCER GENOTYPE IS ASSOCIATED WITH RESPONSE TO HCV-SPECIFIC THERAPY IN HIV-POSITIVE PATIENTS WITH ACUTE HEPATITIS CNattermann, J. / Vogel, M. / Nischalke, H. D. / Danta, M. / Ahlenstiel, G. / Michalk, M. / Sauerbruch, T. / Rockstroh, J. / Spengler1 for the Kompetenznetz Hepatitis, U. et al. | 2008
- S306
-
819 HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ALBINTERFERON ALFA-2B PLUS RIBAVIRIN IN IFN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS CPianko, S. / Yoshida, E. / Zeuzem, S. / Benhamou, Y. / Bain, V. / Pulkstenis, E. / McHutchison, J. G. / Subramanian, G. M. et al. | 2008
- S307
-
821 RELATIONSHIP BETWEEN PLASMACYTOID AND MYELOID DENDRITIC CELLS AND RESPONSE TO ANTIVIRAL THERAPYAndrieu, M. / Middendorp, E. / Mallet, V. / Gaston, J. / Vimeux, L. / Ahloulay, M. / Fernandes, S. / Vallet-Pichard, A. / Nascimbeni, M. / Nalpas, B. et al. | 2008
- S309
-
826 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALTPuoti, C. / Pellicelli, A. M. / Romano, M. / Guarisco, R. / Mecenate, F. / Barbarini, G. / Mazzoni, E. / Barlattani, A. / Picardi, A. / Paffetti, A. et al. | 2008
- S311
-
831 RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED TRIAL OF NITAZOXANIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4Rossignol, J. F. / Kabil, S. M. / El-Gohary, Y. / Keeffe, E. B. et al. | 2008
- S313
-
836 DIFFERENCES IN VIROLOGIC RESPONSE PATTERNS BETWEEN HIV/HCV CO-INFECTED AND HCV MONO-INFECTED PATIENTS TREATED WITH PEGINTERFERON AND RIBAVIRIN WITH DOSE ADJUSTED TO BODY WEIGHT (1000-1200 MG/DAY)Tural, C. / Galeras, J. A. / Planas, R. / Coll, S. / Jou, A. / Cirera, I. / Sirera, G. / Garcia-Retortillo, M. / Tor, J. / Clotet, B. et al. | 2008
- S314
-
839 TWELVE WEEKS OF TREATMENT IS INSUFFICIENT FOR HCV GENOTYPE 2 AND 3 INFECTED PATIENTS WITH STEATOSISWestin, J. / Lagging, M. / Pedersen, C. / Rauning Buhl, M. / Farkkila, M. / Langeland, N. / Morch, K. / Alsio, A. / Norkrans, G. et al. | 2008
- S315
-
841 EFFICACY AND SAFETY OF 2 YEARS MAINTENANCE THERAPY WITH PEGINTERFERON ALPHA-2A IN CHRONIC HEPATITIS C: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (FIBROSYS)Zarski, J. P. / Sturm, N. / Desmorat, H. / Melin, P. / Raabe, J. J. / Bonny, C. / Sogni, P. / Pinta, A. / Rouanet, S. / Cheveau, A. et al. | 2008
- S318
-
849 HOST FACTOR TARGETING THERAPY GIVE A NEW INSIGHT TO INTRACTABLE CHRONIC HEPATITIS CInoue, K. / Watanabe, T. / Yoshiba, M. et al. | 2008
- S320
-
854 RESULTS OF A SAFETY, TOLERABILITY AND PHARMACOKINETIC PHASE I STUDY OF VCH-916, A NOVEL POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE ASCENDING DOSES IN HEALTHY VOLUNTEERSProulx, L. / Bourgault, B. / Chauret, N. / Larouche, R. / Tanguay, M. / Thibert, R. et al. | 2008
- S321
-
857 NEUROPHYSIOLOGY OF FATIGUE IN PRIMARY BILIARY CIRRHOSIS SUGGESTS A CENTRAL ORIGIN AND A MOTIVATIONAL IMPAIRMENTCocchi, C. A. / Cerri, G. / Montagna, M. / Zuin, M. / Invernizzi, P. / Podda, M. / Cavallari, P. / Selmi, C. et al. | 2008
- S322
-
859 ANALYSIS OF CLASSE II HLA IN PATIENTS WITH CHRONIC HEPATITIS C WITH CHARACTERISTICS OF AUTOIMMUNE HEPATITISTani, C. M. / Abrantes-Lemos, C. P. / Nakhle, M. C. / Preuhs-Filho, G. / Rodrigues, H. / Deguti, M. M. / Kalil, J. / Carrilho, F. J. / Cancado, E. L. et al. | 2008
- S323
-
862 DOES AUTOIMMUNE PANCREATITIS EXIST IN CHILDHOOD? A TWENTY-YEAR SINGLE CENTRE RETROSPECTIVE REVIEWGrammatikopoulos, T. / Davies, E. / Davenport, M. / Harrison, P. / Samyn, M. / Mieli-Vergani, G. / Hadzic, N. et al. | 2008
- S324
-
864 STANDARDISED MORTALITY RATIO IN AUTOIMMUNE HEPATITIS (AIH)Hoeroldt, B. / McFarlane, E. / Campell, M. / Basumani, P. / Karajeh, M. / Gleeson, D. et al. | 2008
- S325
-
867 IMPAIRMENT OF CD8+CD28- T SUPPRESSOR CELL FUNCTION IN PRIMARY BILIARY CIRRHOSISInvernizzi, P. / Fenoglio, D. / Bernuzzi, F. / Fravega, M. / Ferrera, A. / Filaci, G. / Picciotto, A. / Pozzoli, V. / Podda, M. / Indiveri, F. et al. | 2008
- S326
-
869 ANALYSIS OF SPECIFIC AUTOANTIBODY PROFILES IN PRIMARY BILIARY LIVER CIRRHOSISJanssen, A. / Meyer, W. / Scheper, T. / Komorowski, L. / Probst, C. / Schlumberger, W. / Bogdanos, D. / Vergani, D. / Stocker, W. et al. | 2008
- S327
-
872 CHARACTERIZATION OF CD4 T-CELL IMMUNE RESPONSE TO NUCLEOPORIN P62 IN PATIENTS WITH PRIMARY BILIARY CIRRHOSISMeda, F. / Longhi, M. S. / Bogdanos, D. P. / Invernizzi, P. / Ma, Y. / Mieli-Vergani, G. / Wesierska-Gadek, J. / Zuin, M. / Podda, M. / Vergani, D. et al. | 2008
- S331
-
883 EPIDEMIOLOGY AND THE INITIAL PRESENTATION OF AUTOIMMUNE HEPATITIS TYPE 1 IN SWEDEN, A NATIONWIDE STUDYWerner, M. / Prytz, H. / Ohlsson, B. / Almer, S. / Bjornsson, E. / Bergquist, A. / Wallerstedt, S. / Sandberg-Gertzen, H. / Hultcrantz, R. / Sangfelt, P. et al. | 2008
- S332
-
886 HEPCIDIN REGULATION IN WILD-TYPE AND HFE-/MICE IN RESPONSE TO ALCOHOL CONSUMPTION: EVIDENCE FOR AN ALCOHOL-INDUCED HYPOXIC RESPONSEFletcher, L. M. / Heritage, M. L. / Murphy, T. L. / Bridle, K. R. / Anderson, G. J. / Crawford, D. H. et al. | 2008
- S334
-
891 HEPATIC EFFECTS OF ROSIGLITAZONE IN RATS WITH THE METABOLIC SYNDROMEAckerman, Z. / Oron-Herman, M. / Peleg, E. / Safadi, R. / Pappo, O. / Grozovski, M. et al. | 2008
- S335
-
894 COMBINED GLUTATHIONE-S-TRANSFERASE M1 AND T1 GENETIC POLYMORPHISM AND SUSCEPTIBILITY TO DEVELOP DRUG-INDUCED IDIOSYNCRATIC LIVER INJURY (DILI)Andrade, R. J. / Martinez, C. / Ulzurrun, E. / Garcia-Martin, E. / Agundez, J. / Borraz, Y. / Lopez-Ortega, S. / Fernandez-Castaner, A. / Pelaez, G. / Romero-Gomez, M. et al. | 2008
- S336
-
897 LOW HEPATIC IRON BURDEN IN MORBIDLY OBESE WOMEN: A LINK WITH CHRONIC INFLAMMATIONAnty, R. / Dahman, M. / Bekri, S. / Iannelli, A. / Gual, P. / Staccini-Myx, A. / Saint-Paul, M. C. / Huet, P. M. / Srai, S. K. / Unwin, R. et al. | 2008
- S338
-
903 GENE EXPRESSIONS AFFECTING STEATOSIS AND OXIDATIVE STRESS IN FRUCTOSE-INDUCED NONALCOHOLIC FATTY LIVER DISEASE IN RATSSchmilovitz-Weiss, H. / Hochhauser, E. / Pappo, O. / Yitzhaki, S. / Ackerman, Z. / Cheporko, Y. / Shainberg, A. / Grossman, E. / Leibovitz, A. / Ben-Ari, Z. et al. | 2008
- S340
-
908 NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN BRAZIL: CLINICAL AND HISTOLOGICAL PROFILECotrim, H. P. / Parise, E. R. / Leite, N. / Oliveira, C. / Martinelli, A. / Galizzi, J. / Silva, R. C. / Mattos, A. / Pereira, L. / Amorim, W. et al. | 2008
- S342
-
913 PREVALENCE AND RISK FACTORS OF HEPATIC STEATOSIS AND ITS IMPACT ON LIVER INJURY IN CHINESE PATIENTS WITH CHRONIC HEPATITIS BShi, J. P. / Fan, J. G. / Wu, R. / Gao, X. / Zhang, L. / Wang, H. / Farrell, G. C. et al. | 2008
- S343
-
916 ENHANCED SREBP-2 EXPRESSION AND FREE CHOLESTEROL LEVELS IN HUMAN NASHCaballero, F. / Bataller, R. / Lacy, A. / Fernandez-Checa, J. C. / Caballeria, J. / Garcia-Ruiz, C. et al. | 2008
- S344
-
919 EVALUATION OF PATIENTS WITH NAFLD WITH OR WITHOUT INCREASED ALTFracanzani, A. L. / Valenti, L. / Bugianesi, E. / Marchesini, G. / Andreoletti, M. / Colli, A. / Bertelli, C. / Fatta, E. / Fargion, S. et al. | 2008
- S346
-
924 ARE ANGIOTENSIN-RECEPTOR BLOCKERS CANDIDATES FOR THE FIRST CHOICE TREATMENT IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) ASSOCIATED TO MILD-TO MODERATE HYPERTENSION?Georgescu, E. F. / Ionescu, R. / Georgescu, M. / Florescu, G. / Dobrinescu, A. / Vancica, L. / Niculescu, M. et al. | 2008
- S347
-
927 PROPOFOL ENHANCES ANTIOXIDANT CAPACITY IN A RAT MODEL OF ACUTE LIVER INJURY INDUCED BY PARACETAMOL INTOXICATIONGrypioti, A. D. / Mykoniatis, M. G. / Demopoulos, C. A. / Daifoti, Z. / Kostopanagiotou, G. et al. | 2008
- S348
-
930 ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER ATTENUATES THE PROGRESSION OF NONALCOHOLIC STEATOHEPATITIS (NASH)Hirose, A. / Ono, M. / Saibara, T. / Nozaki, Y. / Takahashi, M. / Iwasaki, S. / Oben, J. A. / Onishi, S. et al. | 2008
- S349
-
933 REPORT OF AN ASSOCIATION BETWEEM LOW THIGH FAT AND NON-ALCOHOLIC FATTY LIVER DISEASEJun, D. W. / Han, J. H. / Kim, S. H. / Jang, E. C. / Song, M. H. / Jo, Y. J. / Park, Y. S. et al. | 2008
- S350
-
936 EFFECT OF ACETAMINOPHEN AT DIFFERENT DOSES ON INDUCIBLE NITRIC OXIDE SYNTHASE (INOS) EXPRESSION IN RAT LIVER TISSUEKocak, A. / Gokcimen, A. et al. | 2008
- S351
-
939 IL-6 INDUCED GP130 DEPENDENT STAT3 ACTIVATION IN HEPATOCYTES PROTECTS AGAINST INITIATION AND PROGRESSION OF STEATOHEPATITIS IN MICEKroy, D. C. / Beraza, N. / Dierssen, U. / Sander, L. E. / Plum, W. / Erschfeld, S. / Gassler, N. / Trautwein, C. / Streetz, K. L. et al. | 2008
- S354
-
947 FEASIBILITY AND PERFORMANCE OF THE LIVER STIFFNESS (LSM) MEASUREMENT FOR THE DIAGNOSIS OF FIBROSIS IN NAFLDMahmoudi, A. / Nkontchou, G. / Lemoine, M. / Marty, J. R. / Carrie, N. G. / Lemaire, V. G. / Trinchet, J. C. / Beaugrand, M. et al. | 2008
- S355
-
950 TOLERANCE AND EFFICACY OF THE MARS SYSTEM IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS NON-RESPONDERS TO STEROIDS: A PILOT STUDYBoitard, J. / Louvet, A. / Bismuth, B. / Dharancy, S. / Wartel, F. / Canva-Delcambre, V. / Deltenre, P. / Jude, B. / Fourrier, F. / Mathurin, P. et al. | 2008
- S356
-
953 EARLY LIVER BIOPSY IS CRUCIAL FOR ACCURATE DIAGNOSIS OF ALCOHOLIC HEPATITIS AND PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN PATIENTS WITH DECOMPENSATED ALCOHOLIC LIVER DISEASEMookerjee, R. P. / Lackner, C. / Stadlabauer, V. / Deheragoda, M. / Jalan, R. et al. | 2008
- S357
-
956 PHOSPHODIESTERASE III INHIBITOR OVERCOMES RAT SINUSOIDAL OBSTRUCTION SYNDROME THROUGH HEME OXYGENASE-1 INDUCTIONNarita, M. / Hatano, E. / Tamaki, N. / Iwaisako, K. / Seo, S. / Nagata, H. / Yanagida, A. / Asechi, H. / Ikai, I. / Uemoto, S. et al. | 2008
- S360
-
964 THE PRESENCE OF TWO OR MORE METABOLIC ALTERATIONS AND HEPATIC STEATOSIS CHARACTERIZES THE DYSMETABOLIC IRON OVERLOAD SYNDROMERiva, A. / Trombini, P. / Mariani, R. / Salvioni, A. / Coletti, S. / Bonfadini, S. / Paolini, V. / Pozzi, M. / Bovo, G. / Piperno, A. et al. | 2008
- S361
-
967 MR ELASTOGRAPHY OF DIETARY STEATOHEPATITIS IN THE RATSalameh, N. / Larrat, B. / Abarca-Quinones, J. / Leclercq, I. / Sinkus, R. / Van Beers, B. E. et al. | 2008
- S362
-
970 FREE FATTY ACID INDUCE OXIDATIVE STRESS IN HEPG2-CELL. PROTECTIVE ROLE OF ANTI-OXIDANT SUBSTANCES AND ADIPONECTINSoardo, G. / Donnini, D. / Pagano, C. / Milocco, C. / Domenis, L. / De Silvestri, D. / Cappello, D. / Dibenedetto, A. G. / Sechi, L. A. et al. | 2008
- S363
-
973 SEVERE HEPATOTOXICITY AFTER INGESTION OF HERBALIFE NUTRITIONAL SUPPLEMENTS CONTAMINATED WITH BACILLUS SUBTILISStickel, F. / Droz, S. / Patsenker, E. / Boegli-Stuber, K. / Aebi, B. / Wilkens, L. / Leib, S. L. et al. | 2008
- S364
-
976 OBESITY INDUCED HEPATIC OXIDATIVE STRESS DOWN-REGULATE THE LEVEL OF CIRCULATING ENDOTHELIAL PROGENITOR CELLSTsai, C. H. / Wu, M. Y. / Chang, H. H. / Lin, H. C. / Lee, T. Y. et al. | 2008
- S365
-
979 VIUSID, A NUTRITIONAL SUPLEMENT, IN COMBINATION WITH DIET AND EXERCISE AS INITIAL STRATEGY OF TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITISGomez, E. V. / Rodriguez de Miranda, A. / Oramas, B. G. / Soler, E. A. et al. | 2008
- S366
-
982 PHLEBOTOMY IS ASSOCIATED WITH AN IMPROVEMENT IN LIVER ENZYMES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND INCREASED HEPATIC IRON STORESWilliams, E. J. / Dixon, J. / Powell, L. W. / Macdonald, G. A. et al. | 2008
- S367
-
985 THE IMPACT OF LONG-TERM PIOGLITAZONE THERAPY ON ABNORMAL LIVER ENZYMES IN TYPE 2 DIABETESYeap, P. M. / Lockman, K. A. / Boyd, M. / Jaap, A. J. / Hayes, P. C. et al. | 2008
- S369
-
989 BUDESONIDE 3MG TID IS SUPERIOR TO PREDNISONE IN COMBINATION WITH AZATHIOPRINE IN THE TREATMENT OF AUTOIMMUNE HEPATITISManns, M. P. / Bahr, M. J. / Woynarowski, M. / Kreisel, W. / Oren, R. / Gunther, R. / Hultcrantz, R. / Proels, M. / Rust, C. / Spengler, U. et al. | 2008
- S370
-
991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDYSulkowski, M. / Lawitz, E. / Shiffman, M. L. / Muir, A. J. / Galler, G. / McCone, J. / Nyberg, L. / Lee, W. M. / Ghalib, R. / Schiff, E. et al. | 2008
- S373
-
998 ENTECAVIR (ETV) RESULTS IN HIGHER HBV DNA REDUCTION VERSUS ADEFOVIR (ADV) IN ANTIVIRAL-NAIVE HBEAG(+) ADULTS WITH HIGH HBVDNA: WEEK 96 RESULTS (E.A.R.L.Y. STUDY)Leung, N. / Peng, C. Y. / Sollano, J. / Lesmana, L. / Yuen, M. F. / Jeffers, L. / Hann, H. W. / Sherman, M. / Diva, U. / Mencarini, K. et al. | 2008
- S374
-
1000 A STUDY OF TELAPREVIR (TVR) WITH PEGINTERFERON ALFA-2A (P) AND RIBAVIRIN (R) IN SUBJECTS WITH WELL-DOCUMENTED PRIOR P/R NULL RESPONSE, NON-RESPONSE OR RELAPSE: PRELIMINARY RESULTSPoordad, F. / Shiffman, M. / Sherman, K. / Smith, J. / Yao, M. / George, S. / Adda, N. / McHutchison, J. et al. | 2008
- S377
-
Author Index| 2008
- XVIII
-
Subject Index| 2008
-
4 PROVE1: RESULTS FROM A PHASE 2 STUDY OF TELAPREVIR WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH HEPATITIS CMchutchison, J. G. / Everson, G. T. / Gordon, S. C. / Jacobson, I. / Kauffman, R. / McNair, L. / Muir, A. et al. | 2008
-
6 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH HIGHER OVERALL MORTALITY AND LIVER RELATED MORTALITYOng, J. P. / Pitts, A. / Younossi, Z. M. et al. | 2008
-
11 THE EFFECT OF RIBAVIRIN ON DENDRITIC CELL MATURATION AND CYTOKINE PRODUCTIONBarker, S. J. / Semper, A. E. / Rosenberg, W. M. et al. | 2008
-
19 DEVELOPMENT OF NOVEL HYPERGLYGOSYLATED TYPE 1 INTERFERONS: A STRATEGY TO IMPROVE PK PERFORMANCE WITHOUT LOSS OF BIOLOGICAL POTENCYBlatt, L. M. / Seiwert, S. / Beigelman, L. et al. | 2008
-
35 INCREASED FERRITIN PREDICTS VASCULAR DAMAGE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEValenti, L. / Burdick, L. / Bertelli, C. / Fargion, S. / Fracanzani, A. L. et al. | 2008
-
41 GBA2 DEFICIENCY LEADS TO ZONAL GLUCOSYLCERAMIDE ACCUMULATION AND INCREASED APOPTOSIS IN THE LIVERYildiz, Y. / Matern, H. / Matern, S. / Sauerbruch, T. / Lammert, F. et al. | 2008
-
52 THE ROLE OF E-TYPE CYCLINS AND G1-S PHASE TRANSITION IN HEPATIC FIBROGENESISNevzorova, Y. A. / Moro, N. / Gassler, N. / Sicinski, P. / Trautwein, C. / Liedtke, C. et al. | 2008
-
67 POTENT ANTIVIRAL ACTIVITY OF SECOND GENERATION NUCLEOSIDE INHIBITORS, IDX102 AND IDX184, IN HCV-INFECTED CHIMPANZEESStandring, D. N. / Lanford, R. / Cretton-Scott, E. / Licklider, L. / Larsson, M. / Pierra, C. / Gosselin, G. / Perigaud, C. / Surleraux, D. / Mayes, B. et al. | 2008
-
107 INSULIN RESISTANCE, SERUM ADIPOKINES AND THE RISK OF FIBROSIS PROGRESSION IN PATIENTS TRANSPLANTED FOR HEPATITIS C: A PROSPECTIVE COHORT STUDYVeldt, B. J. / Poterucha, J. J. / Watt, K. D. / Wiesner, R. H. / Hay, J. E. / Rosen, C. B. / Heimbach, J. K. / Janssen, H. L. / Charlton, M. R. et al. | 2008
-
135 HEPATOCYTE SPECIFIC IKK2 DELETION CAUSES IMBALANCED NF-kB ACTIVATION AFTER PARTIAL HEPATECTOMY AND LEADS TO AN EARLIER RESOLUTION OF LIVER DAMAGEMalato, Y. / Beraza, N. / Sander, L. E. / Almasaoudi, M. / Liedtke, C. / Trautwein, C. et al. | 2008
-
155 NON-UNIFORM REGIONAL LIVER REGENERATION AFTER HEPATIC SURGERY WELL CORRELATES WITH COMPUTATIONALLY SIMULATED INCREASES IN BLOOD FLOW AND PRESSURE IN PORTAL BRANCHESIimuro, Y. / Saito, S. / Yamanaka, J. / Hirano, T. / Kuroda, N. / Okada, T. / Sugimoto, T. / Asano, Y. / Uyama, N. / Uda, Y. et al. | 2008
-
171 MAP KINASE-DEPENDENT PATHWAYS ARE ACTIVATED DURING PROGRAMMED CELL DEATH IN A VIRAL MODEL OF FULMINANT HEPATIC FAILUREGarcia-Lastra, R. / Alvarez, M. / San-Miguel, B. / Jorquera, F. / Gonzalez-Gallego, J. / Tunon, M. J. et al. | 2008
-
190 GRAFT DYSFUNCTION (GD) IN HBV RECURRENCEFREE RECIPIENTS IS ASSOCIATED WITH SERUM AUTOANTIBODIES REACTIVITYDonato, M. F. / Arosio, E. / Agnelli, F. / Rigamonti, C. / Vigano, M. / Caccamo, L. / Lampertico, P. / Rossi, G. / Colombo, M. et al. | 2008
-
244 ANGIOGENESIS IN PORTAL HYPERTENSIVE NAD(P)HOXIDASE-KNOCKOUT-MICE IS MEDIATED BY A DIFFERENT PATHWAY THAN IN WILDTYPE ANIMALSAngermayr, B. / Reiberger, T. / Rohr-Udilova, N. / Mitterhauser, M. / Cejka, D. / Peck-Radosavljevic, M. et al. | 2008
-
255 ACTIVATION OF HEPATIC STELLATE CELLS FOLLOWING PHAGOCYTOSIS OF LYMPHOCYTES, A NOVEL PATHWAY OF FIBROGENESISMuhanna, N. / Doron, S. / Wald, O. / Horani, A. / Eid, A. / Pappo, O. / Friedman, S. / Safadi, R. et al. | 2008
-
258 ANTIFIBROTIC EFFECT OF CURCUMIN ON PROLONGED BILE DUCT OBSTRUCTION-INDUCED CIRRHOSIS IN RATSReyes-Gordillo, K. / Segovia, J. / Shibayama, M. / Tsutsumi, V. / Vergara, P. / Moreno, M. G. / Muriel, P. et al. | 2008
-
269 THIOACETAMIDE-INDUCED FULMINANT HEPATIC ENCEPHALOPATHY ON ADULT RAT BRAIN PARAMETERS: CORRELATION WITH THE EFFECTS PRODUCED BY IN VITRO TREATMENT WITH AMMONIAZarros, A. / Theocharis, S. / Skandali, N. / Tsakiris, S. et al. | 2008
-
276 PRELIMINARY EFFICACY AND SAFETY OF REPEATED ORAL DOSES OF NCX-1000 FOR THE TREATMENT OF PORTAL HYPERTENSION. A DOUBLE-BLIND, PROOF OF CONCEPT, DOSE ESCALATING STUDYTurnes, J. / Raffa, S. / Abraldes, J. G. / Garcia-Pagan, J. C. / Gagnon, C. / Spenard, J. / Bosch, J. et al. | 2008
-
295 LOW CARDIAC INDEX PREDICTS SURVIVAL AND RENAL FAILURE IN PATIENTS WITH ASCITES. EVIDENCE OF A HEART-KIDNEY AXIS IN CIRRHOSISKrag, A. / Bendtsen, F. / Henriksen, J. H. / Moller, S. et al. | 2008
-
303 ARE REAGENT STRIPS OF VALUE IN THE DIAGNOSIS OF SPONTANEOUS ASCITES INFECTIONS? A CRITICAL REVIEW OF THE LITERATURENguyen-Khac, E. / Cadranel, J. F. / Thevenot, T. / Nousbaum, J. B. et al. | 2008
-
307 THE COURSE OF CHRONIC INFECTION WITH HEPATITIS DELTA VIRUS: A 20-YEARS COHORT STUDY OF 299 ITALIAN PATIENTSRomeo, R. / Sangiovanni, A. / Rumi, M. / Russo, A. / Del Ninno, E. / Ronchi, G. / Colombo, M. et al. | 2008
-
338 ONCOLYTIC VIROTHERAPY AND THE PROTEASOME INHIBITOR BORTEZOMIB ACT SYNERGISTICALLY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMABoozari, B. / Wirth, T. C. / Woller, N. / Manns, M. P. / Kubicka, S. / Kuehnel, F. et al. | 2008
-
356 RECENT PROGRESS IN MANAGEMENT OF HEPATOCELLULAR CARCINOMA DIAGNOSED DURING SURVEILLANCE IN JAPANAndo, E. / Kuromatsu, R. / Tanaka, M. / Takata, A. / Fukushima, N. / Sumie, S. / Kurogi, J. / Nagaoka, S. / Inoue, K. / Niizeki, T. et al. | 2008
-
358 HEPATOCELLULAR CARCINOMA IS ASSOCIATED WITH AN IMPAIRED CD4 T CELL IMMUNE RESPONSECabrera, R. / Morelli, G. / Ararat, M. / Soldevila-Pico, C. / Firpi, R. J. / Levy, C. / Machicao, V. / Liu, C. / Nelson, D. R. et al. | 2008
-
Disclosures: commercial relationships| 2008
-
391 CLINICAL SIGNIFICANCE OF VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN PATIENTS WITH HEPATOCELLUAR CARCINOMALee, S. H. / Chung, Y. H. / Kim, J. A. / Shin, H. D. / Lee, D. / Kim, S. E. / Lee, Y. S. / Jang, M. K. / Kim, K. M. / Lim, Y. S. et al. | 2008
-
403 TO RULE OUT HEPATOCELLULAR CARCINOMA IN HIGH RISK PATIENTS: A NOVEL INDEX FOR EXCLUDING HEPATOCELLULAR CARCINOMA IN CENTRAL EUROPEAN IN-PATIENTS WITH LIVER DISEASEQuante, M. / Erhardt, A. / Schmitz, V. / Caselmann, W. / Sauerbruch, T. / Rabe, C. et al. | 2008
-
423 HCV CORE TUMOR VARIANTS SHIFT TGF-BETA RESPONSES FROM TUMOR SUPPRESSION TO ONCOGENESIS IN PRIMARY HUMAN AND MOUSE HEPATOCYTESBattaglia, S. / Nobilet, S. / Bregerie, O. / Gigou, M. / Charneau, P. / Samuel, D. / Brechot, C. / Bourgeade, M. F. et al. | 2008
-
426 INHIBITION OF THE SQUALENE SYNTHASE OR STAR SILENCING INCREASES THE SUSCEPTIBILITY OF HEPATOCELLULAR CARCINOMA TO CHEMOTHERAPYMontero, J. / Morales, A. / Llacuna, L. / Lluis, J. M. / Garcia-Ruiz, C. / Colell, A. / Fernandez-Checa, J. C. et al. | 2008
-
427 IRS-4 DETERMINES SURVIVAL IN A HUMAN HEPATOCARCINOMA CELL LINE (HEPG2) SUBJECTED TO TNF-ALPHA PLUS ACTINOMYCIN D THERAPYCuevas, E. P. / Roman, I. D. / Escribano, O. / Chiloeches, A. / Monserrat, J. / Arias, A. A. / Fernandez-Moreno, M. D. / Guijarro, L. G. et al. | 2008
-
469 C1-3 RECOMBINANT ANTIBODY TARGETING MYOFIBROBLASTS - SPECIFIC APOPTOSIS REVERSES FIBROSIS IN A SUSTAINED INJURY MOUSE MODELDouglass, A. / Wallace, K. / Parr, R. / Park, J. / Durward, E. / Broadbent, I. / Barelle, C. / Porter, A. J. / Wright, M. C. et al. | 2008
-
476 PLATELETS REDUCE LIVER FIBROSIS IN RATSKohno, K. / Hashimoto, I. / Nakano, Y. / Murata, S. / Kawasaki, T. / Myronovych, A. / Hisakura, K. / Watanabe, M. / Ohkohchi, N. et al. | 2008
-
482 ACETYLCHOLINE INDUCES FIBROGENIC EFFECTS IN HUMAN PRIMARY HEPATIC STELLATE CELLSMorgan, M. / Sigala, B. / Selden, C. / Diehl, A. M. / Oben, J. A. et al. | 2008
-
487 THE INTERMEDIATE FILAMENT PROTEIN SYNCOILIN MEDIATES INTRACELLULAR CALCIUM INCREASE IN MOUSE HEPATIC STELLATE CELLSVan Rossen, E. / Liu, Z. / van Grunsven, L. A. / Van der Straeten, J. / Van Daele, J. / Roskams, T. / Timmermans, J. P. / Reynaert, H. / Geerts, A. et al. | 2008
-
499 PXR ACTIVATION REDUCES HEPATIC TNF-ALPHA LEVELS - A MECHANISM FOR INHIBITING LIVER FIBROSISWallace, K. / Konstantinou, D. K. / Cowie, D. E. / Tucker, S. J. / Marek, C. J. / Durward, E. / Koruth, M. / Mann, D. A. / Wright, M. C. et al. | 2008
-
516 EXTRA-CELLULAR MATRIX REMODELLING IS CRITICAL TO THE OVAL CELL RESPONSE AFTER CHRONIC LIVER INJURYKallis, Y. N. / Bird, T. G. / Iredale, J. P. / Forbes, S. J. et al. | 2008
-
565 IMPAIRED INNATE IMMUNE RESPONSES IN PATIENTS WITH EARLY ACUTE HBV INFECTIONDunn, C. / Brendish, N. / Jones, M. / Nebbia, G. / Brown, D. / Gilson, R. J. / Dusheiko, G. M. / Jacobs, M. / Maini, M. K. et al. | 2008
-
589 HEPATITIS C VIRUS REPLICATION SENSITIZES HUMAN HEPATOMA CELLS TO TRAIL-INDUCED APOPTOSISGorke, S. / Fischer, R. / Rau, S. J. / Lan, L. / Wakita, T. / Blum, H. E. / Zeisel, M. B. / Baumert, T. F. et al. | 2008
-
594 FACTORS ASSOCIATED WITH THE EXPRESSION OF THE SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION (STAT) IN CHRONIC HEPATITIS CMiyaaki, H. / Ichikawa, T. / Nakao, K. / Takeshita, S. / Shibata, H. / Ozawa, E. / Akiyama, M. / Miuma, S. / Fujimoto, M. / Eguchi, K. et al. | 2008
-
637 RAPID SELECTION OF ESCAPE MUTATIONS WITHIN NS3 1406 CTL EPITOPE DURING ACUTE HEPATITIS C WITH SEQUENCE VARIABILITY DUE TO IMMUNE PRESSUREUlsenheimer, A. / Paranhos-Baccala, G. / Komurian-Pradel, F. / Diepolder, H. M. / Heeg, M. / Raziorrouh, B. / Zachoval, R. / Berg, T. / Jung, M. C. / Gruener, N. H. et al. | 2008
-
658 LOWER HEPATITIS B VIRUS PRODUCTIVITY IN THE HBeAg-NEGATIVE PHASE IS NOT DUE TO THE EMERGENCE OF VIRAL MUTATIONS WITHIN REGULATORY REGIONSKoepke, A. / Volz, T. / Luetgehetmann, M. / Lohse, A. / Petersen, J. / Dandri, M. et al. | 2008
-
668 THE LONG-TERM PROTECTIVE EFFECT OF HEPATITIS B VACCINE AND THE TIMING OF BOOSTER IMMUNIZATION IN ADULTSShibasaki, K. / Hirono, H. / Watanabe, T. / Hasegawa, K. / Soga, K. et al. | 2008
-
695 LOW RATE OF DELAYED RESPONSE IN LAMIVUDINE EXPERIENCED HIV/HBV CO-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)Lada, O. / Gervais, A. / Branger, M. / Peytavin, G. / Colin, G. / Fraqueiro, G. / Males, S. / Martinot-Peignoux, M. / Matheron, S. / Marcellin, P. et al. | 2008
-
696 ADD ON ADEFOVIR PREVENTS THE EMERGENCE OF ADV RESISTANCE IN LAMIVUDINE-RESISTANT PATIENTS: A 4-YEAR STUDYLampertico, P. / Vigano, M. / Manenti, E. / Iavarone, M. / Colombo, M. et al. | 2008
-
732 TOWARD INTELLIGENT VIRTUAL BIOPSY: USING ARTIFICIAL INTELLIGENCE TO PREDICT FIBROSIS STAGE IN CHRONIC HEPATITIS C PATIENTS WITHOUT BIOPSYFloares, A. / Lupsor, M. / Stefanescu, H. / Sparchez, Z. / Serban, A. / Suteu, T. / Badea, R. et al. | 2008
-
739 CORRELATION BETWEEN SURROGATE ESTIMATES AND DIRECT MEASURE OF INSULIN RESISTANCE IN PATIENTS WITH CHRONIC HEPATITIS C: IMPACT OF BODY WEIGHTKhalili, M. / Shah, V. / Ayala, C. / Maher, J. et al. | 2008
-
771 ALCOHOL CONSUMPTION DURING HEPATITIS C THERAPY IN PATIENTS OF THE SWISS HEPATITIS C COHORT STUDYBruggmann, P. / Dampz, M. / Falcato, L. M. et al. | 2008
-
777 SUSTAINED VIROLOGICAL RESPONSE IS ASSOCIATED WITH A LOWER RISK OF COMPLICATIONS AND HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HCV RELATED CIRRHOSISCardoso, A. C. / Moucari, R. / Giuily, N. / Figueiredo-Mendes, C. / Boyer, N. / Ripault, M. P. / Castelnau, C. / Asselah, T. / Martinot-Peignoux, M. / Maylin, S. et al. | 2008
-
807 IMPACT OF VIRAL LOAD AND CIRRHOSIS ON TREATMENT OUTCOME IN HCV GENOTYPE 3-INFECTED PATIENTS: RESULTS OF THE CANADIAN POWER PROGRAMMarotta, P. J. / Cooper, C. L. / Scully, L. J. / Wong, D. K. / Woolstencroft, R. N. / Abadir, N. / Bailey, R. J. et al. | 2008
-
808 ASSESSMENT OF VIROLOGICAL RESPONSE AT BOTH WEEK 4 AND WEEK 12 OPTIMIZES PREDICTION OF PEGINTERFERON ALFA PLUS RIBAVIRIN.TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS CMartinot-Peignoux, M. / Ripault, M. P. / Moucari, R. / Boyer, N. / Maylin, S. / Cardoso, A. C. / Giuily, N. / Castelnau, C. / Pouteau, M. / Bedossa, P. et al. | 2008
-
813 THE EFFECT OF ADDING METFORMIN TO THE TREATMENT OF HEPATITIS C: A PRELIMINARY REPORT OF A RANDOMIZED CONTROLLED TRIALMerat, S. / Jabbari, H. / Sharifi, A. H. / Zaer-Rezaee, H. / Fakharzadeh, E. / Asadi, R. / Shahzamani, K. / Mohammadi, M. / Malekzadeh, R. et al. | 2008
-
820 HCV GENOTYPE 4 IN SUBJECTS UNDERGOING ANTIVIRAL TREATMENT IN ITALYPinzello, G. / Stroffolini, T. / Vinci, M. / Prisco, C. / Bandiera, F. / Memoli, M. / Bacca, D. / Nosotti, L. / Stanzione, M. / Camera, A. et al. | 2008
-
844 GENOTYPIC ANALYSIS OF HCV NS5B VARIANTS SELECTED FROM PATIENTS TREATED WITH VCH-759Nicolas, O. / Boivin, I. / St-Denis, C. / Bedard, J. et al. | 2008
-
846 NATURALLY OCURRING NS3 PROTEASE-INHIBITOR RESISTANT-MUTANT A156T IN THE LIVER OF AN UNTREATED CHRONIC HEPATITIS C PATIENTCubero, M. / Esteban, J. I. / Otero, T. / Sauleda, S. / Bes, M. / Esteban, R. / Guardia, J. / Quer, J. et al. | 2008
-
870 PATIENTS WITH EARLY PBC PREDOMINANTLY DIE FROM NON-LIVER RELATED CAUSESKuiper, E. M. / Hansen, B. E. / de Vries, R. A. / den Ouden-Muller, J. W. / van Erpecum, K. J. / van Buuren, H. R. et al. | 2008
-
875 TREATMENT OF RESISTANT PRURITUS OF CHOLESTASIS WITH ALBUMIN DIALYSIS (MARS). COMBINED ANALYSIS OF PATIENTS FROM THREE CENTERSPares, A. / Herrera, M. / Aviles, J. / Mas, A. et al. | 2008
-
902 DOPPLER PERFUSION INDEX (DPI) IS HIGHLY PREDICTIVE OF THE GRADE OF FATTY LIVER IN OVERWEIGHT PATIENTS WITH NAFLDBellentani, S. / Dugoni, M. / Miglioli, L. / Anderlini, R. / Mariano, M. / Borelli, L. / Battistini, N. C. et al. | 2008
-
938 ACETAMINOPHEN INDUCES SEVERE LIVER INJURY CAUSED BY INCREASED SUSCEPTIBILITY TO OXIDATIVE STRESS IN OBESE KK-AY MICEKon, K. / Ikejima, K. / Aoyama, T. / Arai, K. / Yamashina, S. / Watanabe, S. et al. | 2008
-
949 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) ON CHRONIC HEPATITIS B (CHB) AND C (CHC)Markova, A. A. / Dragneva, S. S. / Antonov, K. / Jelev, D. / Kosseva, O. / Ivanova, R. / Gegova, A. / Mateva, L. et al. | 2008
-
954 RISK FACTORS OF AMINOTRANSFERASE ELEVATION IN A POPULATION OF VIRUS-FREE BLOOD DONORS. A MULTICENTRE STUDYMorisco, F. / Mele, A. / Taliani, G. / Smedile, A. / Caronna, S. / Niro, G. / Levrero, M. / Fiorillo, M. T. / Tosti, M. E. / Stroffolini, T. et al. | 2008
-
969 UCP2 OVEREXPRESSION SENSITIZES NASH LIVER TO ISCHEMIA/REPERFUSION INJURY BY INCREASING MITOCHONDRIAL PROTON LEAKServiddio, G. / Bellanti, F. / Romano, A. D. / Tamborra, R. / Rollo, T. / Bruno, D. / Petrella, A. / Altomare, E. et al. | 2008
-
974 [1-13C]-ACETATE BREATH TEST CLEARLY DISCRIMINATES FATTY LIVER DISEASES FROM CHRONIC VIRAL HEPATITISSugimoto, M. / Urita, Y. / Watanabe, T. / Maeda, T. / Sasaki, Y. / Nakayama, A. / Nanami, M. / Ishii, T. / Hike, K. / Kato, H. et al. | 2008
-
977 A ROLE OF THE DIET-INDUCED OXIDATIVE STRESS IN THE ONSET OF NASHUetake, Y. / Shimosawa, T. / Ikeda, H. / Yatomi, Y. / Fujita, T. et al. | 2008
-
1002 DECLINE OF HBV COVALENTLY CLOSED CIRCULAR DNA DURING TELBIVUDINE AND LAMIVUDINE THERAPYWong, D. K. / Yuen, M. F. / Fung, J. / Wu, R. / Lai, C. L. et al. | 2008
-
43rd Annual Meeting of EASL| 2008
-
Acknowledgements| 2008
-
14 EFFICAY AND SAFETY OF PEGYLATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS AWAITING LIVER TRANSPLANTATION: A CASE-CONTROL STUDYCarrion, J. A. / Martinez-Bauer, E. / Crespo, G. / Garcia-Valdecasas, J. C. / Navasa, N. / Forns, X. et al. | 2008
-
22 STUDIES OF THE POTENTIAL FOR RESISTANCE TO NITAZOXANIDE OR TIZOXANIDEKorba, B. E. / Glenn, J. S. / Ayers, M. S. / Rossignol, J. F. et al. | 2008
-
65 CLONAL ANALYSIS OF MUTATIONS SELECTED IN THE HCV NS3 PROTEASE DOMAIN OF GENOTYPE 1 NON-RESPONDERS TREATED WITH BOCEPREVIR (SCH503034)Susser, S. / Welker, M. W. / Zettler, M. / Wohnsland, A. / Hughes, E. / Ralston, R. / Tong, X. / Zeuzem, S. / Sarrazin, C. et al. | 2008
-
75 TENOFOVIR DISOPROXIL FUMARATE (TDF) IS HIGHLY ACTIVE FOR TREATMENT OF CHRONIC HEPATITIS B IN SUBJECTS WITH CIRRHOSISButi, M. / Hadziyannis, S. / Mathurin, P. / Urbanek, P. / Sherman, M. / Strasser, S. / Wang, C. / Petersen, J. / Sorbel, J. / Mondou, E. et al. | 2008
-
77 FUNCTIONAL COMPARTMENTALIZATION OF HCV NS5A VARIANTS WITHIN THE TUMORAL AND NON-TUMORAL TISSUE FROM PATIENTS WITH HEPATOCELLULAR CARCINOMALerat, H. / Carmouse, S. / Pellerin, M. / Zucman-Rossi, J. / Pawlotsky, J. M. et al. | 2008
-
96 IRON DEPLETION BY DEFEROXAMINE UPREGULATES GLUCOSE UPTAKE AND INSULIN SIGNALING IN HEPATOCYTES AND IN A RAT MODEL OF FATTY LIVERDongiovanni, P. / Valenti, L. / Fracanzani, A. L. / Gatti, S. / Cairo, G. / Fargion, S. et al. | 2008
-
103 VIROLOGICAL AND BIOCHEMICAL RESPONSE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A (40KD) WITH OR WITHOUT LAMIVUDINE: RESULTS OF 4-YEAR FOLLOW-UPMarcellin, P. / Piratvisuth, T. / Brunetto, M. / Bonino, F. / Lau, G. K. / Farci, P. / Yurdaydin, C. / Wu, J. / Popescu, M. et al. | 2008
-
113 OLDER DONOR AGE IS ASSOCIATED WITH INCREASED DONOR OXIDATIVE STRESS AND FAILURE TO RESTORE BASAL PROTEIN GRAFT CONTENT AFTER ISCHEMIA REPERFUSION IN HUMAN LIVER TRANSPLANTATIONGinanni Corradini, S. / Molinaro, A. / Siciliano, M. / Costi, E. / Monticolo, R. / Pirazzi, C. / Burza, M. A. / Merli, M. / Attili, A. F. / Mennini, G. L. et al. | 2008
-
124 HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY COMPLETELY ABROGATES CHOLANGITIS IN THE NOD.C3C4 MOUSE MODEL OF PBCGraham, D. / Chen, M. / Girgis, S. / Zhang, G. / Mason, A. et al. | 2008
-
134 A SWINE LIVER TRANSPLANTATION MODEL OF ISCHEMIA/REPERFUSION INJURY: PROTECTIVE EFFECTS OF THE HEME OXYGENASE-1 PRODUCTSScuderi, V. / Giuliani, A. / Andria, B. / Alimenti, E. / Tammaro, A. / Scala, S. / Attanasio, C. / Corona, M. / Di Napoli, D. / Castaldo, S. et al. | 2008
-
151 PROTECTIVE EFFECT OF PD-L1/PD-1 IN ACUTE HEPATIC ISCHEMIA-REPERFUSION INJURYDorn, C. / Froh, M. / Schuster, K. / Scholmerich, J. / Blank, C. / Hellerbrand, C. et al. | 2008
-
152 OPPOSITIONAL EFFECTS OF IL-10 AND IL-17 DURING IMMUNOLOGICAL TOLERANCE AGAINST CONCANAVALIN AErhardt, A. / Biburger, M. / Tiegs, G. et al. | 2008
-
163 THE CHEMOKINE RECEPTOR CXCR3 IS PROTECTIVE DURING ACUTE CCL4 INDUCED LIVER INJURYMoreno Zaldivar, M. / Berres, M. L. / Schmitz, P. / offermanns, C. / Karlmark, K. R. / Tacke, F. / Gassler, N. / Trautwein, C. / Wasmuth, H. E. et al. | 2008
-
181 DOSE-DEPENDENT REDUCTIONS IN SERUM FERRITIN CORRELATE WITH CHANGES IN SERUM TRANSAMINASE LEVELS DURING LONG-TERM IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE, ICL670)Brissot, P. / Cianciulli, P. / Cario, H. / Rabault, B. / Deugnier, Y. et al. | 2008
-
192 THE LB MODEL: A NEW PROGNOSTIC TOOL FOR PREDICTION OF SHORT TERM SURVIVAL IN PATIENTS WITH END STAGE LIVER DISEASEDuller, D. / Haas, J. / Stadlbauer, V. / Kniepeiss, D. / Palma, S. T. / Gurakuqi, G. / Gallent, H. R. / Iberer, F. / Stauber, R. E. et al. | 2008
-
199 OUTCOME OF RENAL FUNCTION FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH TYPE 1 HEPATORENAL SYNDROMECasciato, P. / Villamil, A. / Marciano, S. / Bandi, J. / Rezzonico, L. / Solari, J. / Galdame, O. / de Santibanes, E. / Gadano, A. et al. | 2008
-
214 DOES THE SYSTEMIC INFLAMMATORY RESPONSE PLAY A ROLE IN THE PATHOGENESIS OF RENAL FAILURE IN ACUTE LIVER FAILURE?Leithead, J. A. / Ferguson, J. W. / Bates, C. M. / Davidson, J. S. / Bathgate, A. / Hayes, P. C. / Simpson, K. J. et al. | 2008
-
217 G-CSF ADMINISTRATION IS NOT RELATED TO PEG-IFN ALFA-2B TREATMENT DURATION NOR RESPONSE IN LIVER TRANSPLANTED PATIENTS WITH HCV RECURRENCELodato, F. / Tame, M. R. / DiGirolamo, M. / Azzaroli, F. / Gramenzi, A. / Berardi, S. / Andreone, P. / Pinna, A. D. / Roda, E. / Mazzella, G. et al. | 2008
-
226 IMPACT OF ETHNICITY ON OUTCOME FOLLOWING LIVER TRANSPLANT (LT)-AN ANALYSIS OF PRETRANSPLANT VARIABLESPleguezuelo, M. / Patch, D. / Burroughs, A. K. / Rolando, N. / OBeirne, J. et al. | 2008